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Vagal afferents transmit signals regarding food-derived stimuli in the 
gastrointestinal (GI) tract to the brain. Vagal mechanoreceptors called 
intraganglionic laminar endings (IGLEs) innervate the smooth muscle wall of GI 
organs and detect stretch and tension to regulate GI reflexes and satiation. 
Brain-derived neurotrophic factor (BDNF) is expressed in the smooth muscle of 
developing GI organs when vagal afferents from the nodose ganglion begin to 
innervate the GI tract. Therefore, it was hypothesized BDNF is necessary for 
development of vagal afferents that innervate this tissue. Targeted smooth 
muscle-specific BDNF homozygous knockout (BDNF SM -/-) mice were 
generated and .vagal afferent innervation and analysis of feeding behavior 
were compared to wild type (wt) mice. IGLEs and axons in the GI tract were 
labeled by injection of the nerve tracer horseradish peroxidase conjugated to 
wheatgerm agglutinin (WGA-HRP) into the nodose ganglion. Nodose ganglion 
neurons were also quantified to investigate the contribution of vagal sensory 
neurons to IGLE density. Meal pattern and microstructure analyses were used 
xiii 
to determine if any underlying changes in the mechanisms that regulate 
feeding were associated with altered vagal function. Contrary to expectations 
for knockout (KO) of a growth factor gene, BDNF SM -/- mice showed 
increased IGLE density in the intestine compared to controls, whereas those 
supplying the stomach exhibited normal density. BDNF SM -/- mice showed an 
increase in total vagal sensory neuron number compared to wild-type (wt) mice 
as well as increases in the number of larger-diameter longitudinal axon bundles 
in the intestine. BDNF SM -/- mice exhibited decreases in meal duration and 
meal size compared to wt mice, suggesting food is more satiating in BDNF SM 
-/- mice compared to controls. Mutants also showed increased satiety ratio, 
suggesting a given amount of food produced greater satiety. Consistent with 
vagal afferent mediation of increased satiation in mutants, initial rate of food 
intake was similar in mutants and controls, but the subsequent sustained intake 
rate over min 6-30 was reduced in mutants.  The increase in vagal sensory 
neuron and axon bundle numbers in BDNF SM -/- mice suggests GI BDNF 












Metabolic homeostasis is a complex process that involves coordinated 
networks of several neural and hormonal interactions in both the central (CNS) 
and peripheral nervous systems (PNS) to maintain energy balance.  In the 
PNS, the control of visceral functions primarily occurs through the autonomic 
nervous system. Many of these visceral functions, such as regulation of heart 
rate, breathing, perspiration, and digestive functions, operate below the level of 
consciousness and are critical to sustaining life. There are two main 
subdivisions that comprise the autonomic nervous system: the sympathetic 
branch, which controls visceral functions during stress, and the 
parasympathetic branch, which regulates visceral functions at rest. The vagus 
nerve is part of the parasympathetic branch of the autonomic system, and 
innervates visceral organs such as the heart, lungs, kidneys, liver, stomach, 
intestine, and bladder, among others. As such, the vagus nerve is important for 
many of the visceral functions necessary to maintain life. In particular, vagal 
innervation of the GI tract is critical for proper regulation of digestive functions 
such as nutrient absorption, gastric motility, secretion, and detection of toxins 




Vagal Circuit Involved in the Regulation of Food Intake 
Vagal satiation signaling occurs through integration of peripheral satiety 
signals from the GI tract with CNS inputs to regulate food intake. The vagus 
nerve is composed of both sensory and motor components that are important 
for digestion and can influence food intake through regulation of 
gastrointestinal reflexes. In general, the sensory component of the vagus 
sends signals to the brain regarding the nutritional status of food in the GI tract 
and contributes to the regulation of digestive vago-vagal reflexes, whereas the 
vagal efferent innervation to the GI tract is the final common pathway that 
integrates peripheral sensory and CNS inputs to effect motor outputs that also 
control digestive functions such as reflexes and motility.  
 After food ingestion, information about the chemical and mechanical 
stimuli derived by the food are detected by sensory receptors in the GI tract 
and are then sent through vagal afferents carried by the solitary tract (TS) in 
the hindbrain. From the TS, excitatory glutamatergic projections continue on to 
the dorsal vagal complex, which is composed of two sensory nuclei, the 
nucleus of the solitary tract (NTS) and the area postrema (AP), and the dorsal 
motor nucleus of the vagus (DMV). The NTS distributes the sensory signals 
that arise from the gut throughout the rest of the brain, primarily through 
connections to the paraventricular nucleus of the hypothalamus (PVN), 
although there are less prominent connections from the NTS to other 
hypothalamic areas, such as the arcuate nucleus (ARC), dorsomedial nucleus 
(DMH), and lateral hypothalamic area (LH). From the PVN, the sensory signals 
3 
 
are sent throughout the rest of the hypothalamus and higher reward centers in 
the brain. Sensory information from the NTS also reaches the hypothalamus 
through the parabrachial nucleus (PBN). After sensory information has been 
processed throughout the brain, motor output responses are generated to 
regulate reflexes that contribute to food intake.  
Vagal Regulation of Short-Term Food Intake 
In addition to its many roles in digestion, the vagus primarily regulates 
short-term controls of food intake. The short term unit of food intake is a meal; 
therefore, vagal regulation of ingestive behavior occurs through meals, rather 
than the overall amount of food intake (Smith 1996). Many manipulations to 
test the role of the vagus in the regulation of food intake have generally not 
affected long-term food intake or body weight, particularly sensory-specific 
vagal manipulations (Berthoud 2008; Fox 2013). For example, rats with vagal 
subdiaphragmatic deafferentation (SDA) ingested larger meals; however the 
animals compensated for the increased meal size with a decrease in meal 
frequency, which resulted in no net change in total amount of food consumed 
(Schwartz et al., 1999). In addition, sensory vagotomy resulted in decreased 
suppression of food intake after intestinal nutrient infusion (Walls et al., 1995). 
These results suggest vagal deafferentation leads to decreased negative 
feedback signaling to the brain. Consistent with this, rats with chemical 
deafferentation using the neurotoxin capsaicin showed increased short term 
food intake and reduced suppression of food intake after CCK administration 
(Ritter & Ladenheim 1985). Capsaicin, the active ingredient in red chili 
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peppers, is a selective neurotoxin that destroys small-diameter sensory 
neurons, which make up a large portion of sensory innervation to the gut: 
approximately 50% of neurons in the nodose ganglion that project to the 
stomach and 70% of those innervating the duodenum are responsive to 
capsaicin (Peters et al., 2006). In addition to surgical and chemical 
manipulation of vagal afferents to study the contribution of the vagus in 
regulation of food intake, genetic ablation that interferes with vagal signaling 
also leads to changes in meal termination, or satiation, rather than more 
hedonic or motivational controls of food intake. For example, neutrophin-4 (NT-
4) knockout mice showed a 90% loss of vagal mechanoreceptors in the 
intestine, which was associated with decreased satiation, as demonstrated by 
increased meal size on a liquid diet and increased meal duration on a solid 
diet. These effects were compensated for by trends toward decreased meal 
frequency and decreased feeding rate, resulting in no change in total food 
intake or body weight (Fox et al., 2001a).  
In contrast to the sensory-specific approaches used to determine the 
role of vagal afferents in food regulation, total vagotomy methods that lesion 
both sensory and motor components of vagal innervation to the gut have 
resulted in altered total food intake. Total vagotomy surgeries have resulted in 
a counterintuitive decrease in total food intake that is associated with a loss of 
body weight in both humans and rodents (Faxen et al., 1979; Mordes et al., 
1979; Laskiewicz et al., 2003; Kral et al., 2009). Animals with total vagotomy 
also show a decrease in abdominal body fat (Stearns et al., 2012), suggesting 
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vagal innervation may also play a role in long-term control of body adiposity. 
The decrease in food intake and body adiposity may be due to damaged motor 
innervation that interferes with gastric motility or reflexes, although this is 
unclear (Fox 2013). Manipulations that ablate both sensory and motor vagal 
innervation make it difficult to disentangle the independent roles of each 
component of vagal GI innervation to the regulation of food intake. 
Characterization of Vagal Innervation to the Gut 
Vagal efferents arise from the nucleus ambiguus (NA) and DMV in the 
brainstem, while vagal afferents originate from the nodose ganglion.  The 
majority of total vagal innervation is sensory, as it has been reported that up to 
73% of the total vagal fibers are afferent, and the remaining fibers efferent (Fox 
& Powley 1985; Prechtl & Powley 1985, 1990). Abdominal vagal innervation is 
also primarily sensory, although there appears to be more motor innervation 
than originally thought (Prechtl & Powley 1985, 1990). 
Vagal afferents innervating the GI tract terminate in sensory receptors 
called chemoreceptors and mechanoreceptors, which are located in the 
mucosal/lamina propria and smooth muscle/myenteric plexus walls of the GI 
tract, respectively. These receptors detect chemical and mechanical stimuli 
from food in the GI tract to regulate digestion functions and feeding through GI 
reflexes and negative feedback to the CNS.  However, it is not clear how 
sensory information is encoded and transduced by these receptors, as the 
rapidly-adapting mechanoreceptors in the mucosa also have chemoreceptive 
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properties, in contrast to the mechanoreceptors located in the smooth muscle, 
which are slowly-adapting mechanoreceptors.  
Chemoreceptors detect the chemical components of food and peptides 
and neurotransmitters released by the presence of food. Signals detected by 
chemoreceptors include hormones released from the GI tract. These hormones 
act as nutritional signals regarding the contents of the gut and relay this 
information back to the brain to effect a response (Schwartz et al., 1991; Peters 
et al., 2006; Berthoud 2008; Zhang et al., 2010; Chu et al., 2013). Some of the 
more well-characterized gut hormones that regulate satiety include 
cholecystokinin (CCK), glucagon-like-peptide-1 (GLP-1), and Peptide YY 
(PYY). All of these hormones are released in response to a meal and act to 
decrease short-term food intake through vagal signaling (Schwartz et al., 1991; 
Abbott et al., 2005; Koda et al., 2005; Peters et al., 2006; Rüttimann et al., 
2009). In contrast, ghrelin is the only known appetitive hormone and is 
secreted by the stomach to increase food intake (Bowers et al., 1984; Kojima 
et al., 1999; Wren et al., 2001). Like the satiety hormones released by the GI 
tract, ghrelin also acts via vagal afferent signaling, and there is evidence that 
ghrelin functions to increase food intake by decreasing the sensitivity of vagal 
afferents (Page et al., 2007). There are two primary pathways circulating GI 
hormones utilize to effect responses on digestive functions:  (1) hormones 
released by the gut travel through the blood to act directly in the CNS, and (2) 
receptors located in the gut respond to GI hormones and these signals travel to 
the NTS through vagal afferents. The relative importance and consequences of 
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these two divergent pathways is not clear. For example, there are CCK 
receptors on vagal terminals in the GI tract and on the smooth muscle, but 
CCK receptors are also present in the brain, including the NTS (Hill et al., 
1987; Wank et al., 1992; Ritter et al. 1994; Broberger et al., 2001).  Therefore, 
it is unknown exactly how CCK contributes to regulation of food intake, as there 
are multiple pathways used to effect a response. 
Three main types of vagal afferent chemoreceptors have been 
identified: crypt and villus afferents, which are located in the lamina propria 
within the intestinal mucosa and innervate crypts and villi, respectively 
(Berthoud et al., 1995; Powley et al., 2011), and the more recently identified 
antral gland afferent, located in the antrum of the stomach (Powley et al., 
2011). Villus afferents and their terminals are located in close proximity to 
enterocytes, by which they are thought to indirectly detect chemical signals 
secreted from these cells through a paracrine mechanism (Li et al., 2001; 
Powley et al., 2011). Crypt afferents encircle mucosal crypts in a ring-like 
fashion and have been proposed to have many different functions, including 
relay of paracrine signaling, chemoreception, and mobilization of reflexes. The 
mucosal antral gland afferents are located along the antral wall of the stomach 
and form terminals just below the epithelium of the lumen.  Interestingly, antral 
gland afferents appear to function as both chemo- and mechanoreceptors, as 
these afferents that innervate the antral mucosa of the stomach are responsive 
to both pH and light mechanical stimulation, although not to the same extent as 
manipulations that produced greater tension and stretch that activate 
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mechanoreceptors in the smooth muscle (Clarke & Davison 1978; Powley et 
al., 2011).  
Mechanoreceptors in the smooth muscle wall have been proposed to 
detect stretch and tension, which contribute to satiation through regulation of 
GI reflexes (Phillips & Powley 2000; Fox et al., 2001a; Zagorodnyuk et al., 
2001). Two main types of presumptive vagal mechanoreceptor endings have 
been identified: intramuscular arrays (IMAs) and intraganglionic laminar 
endings (IGLEs).  
The IMA ending type is located primarily in the longitudinal and circular 
muscle layers of the forestomach and the circular layer of the esophageal and 
pyloric sphincters (Berthoud & Powley 1992; Wang & Powley 2000; Fox et al., 
2000). They have also been identified in the intestine, although very rarely. The 
terminals of IMAs are arranged in a rectilinear fashion, parallel to muscle fibers 
and to each other as they course through the smooth muscle. The morphology 
and location of IMAs suggests they serve as stretch and length detectors, as 
they are located almost exclusively where stretching occurs, which include the 
forestomach where food is collected, and the sphincters, which regulate the 
movement of food through the GI tract and prevent reflux of digested food back 
up through the alimentary canal. Mice lacking interstitial cells of Cajal (ICCs), 
also called c-Kit mutant mice, display a selective reduction in IMA density 
compared to wild type (wt) mice, suggesting ICCs are required for normal 
development of IMAs (Fox et al., 2001b). The ICCs are important for peristaltic 
reflexes in the GI tract, as they serve as pacemaker cells that generate slow 
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waves to contract the muscles of the GI tract wall. The ligand for c-Kit 
receptors, steel factor, is also necessary for normal development of IMAs, as 
mice lacking steel also show decreased IMA density and decreased ICC 
number. Steel factor mice ate smaller meals but compensated for decreased 
meal size by increased meal frequency, which resulted in normal daily food 
intake (Fox et al., 2002). The ICC mutations appear to be selective for IMAs, as 
both c-Kit and steel mutant mice displayed normal IGLE structure, distribution, 
and density (Fox et al., 2001b, 2002). Therefore, ICCs have a trophic effect on 
the development or maintenance of IMAs. Electrophysiological evidence 
detailing the function of IMAs has thus far been lacking, but the few studies that 
have attempted to characterize the function of presumptive IMAs are consistent 
with the proposed function of muscle length and stretch receptors (Blackshaw 
et al., 1987; Page & Blackshaw 1998, 1999). 
The other class of vagal afferent mechanoreceptors, the IGLEs, have a 
much greater distribution than IMAs and are located throughout the 
esophagus, stomach, and intestine. The IGLE ending type was first identified 
by Nonidez in the esophagus of the dog in 1946, and was further characterized 
by others (Nonidez 1946; Rodrigo et al., 1975; Neuhuber 1987; Berthoud & 
Powley 1992; Berthoud et al., 1997; Wang & Powley 2000; Fox et al., 2000; 
Zagorodynuk et al., 2001). The IGLEs are the most numerous 
mechanoreceptor class in both the stomach and intestine. They are found most 
densely in the stomach, but also in very high densities in the proximal 
duodenum and decrease caudally down the length of the intestine.  IGLEs are 
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found in the myenteric plexus, between the circular and longitudinal layers of 
the smooth muscle in the GI tract wall. These terminals consist of flattened 
aggregates of terminal puncta in close apposition to myenteric ganglia. It has 
been proposed that IGLEs, due to their morphology and their location in the 
myenteric plexus between the two tissues that comprise the smooth muscle, 
detect the shearing forces between these two muscle layers (Neuhuber & Clerc 
1990). Zagorodynuk et al. (2001) showed vagal afferents to the gut are slowly-
adapting C-fibers that terminate in IGLEs, which respond to muscle tension 
and contraction.  
Functions of Brain-Derived Neurotrophic Factor 
There are many factors that shape the development of vagal afferents 
innervating the GI tract and can therefore influence their function. Function of 
vagal afferents could be impacted through altered development or by altered 
function directly during adulthood. One family of growth factors that is critical to 
the survival of vagal sensory neurons and their projections are the 
neurotrophins. Neurotrophins are important for the growth, differentiation and 
survival of new neurons in development, and the survival and maintenance of 
existing neurons in adulthood. The family of neurotrophins includes nerve 
growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 
(NT-3), NT-4/5, neurotrophin-6 (NT-6), and neurotrophin-7 (NT-7). All of the 
neurotrophins are structurally similar, as they share a high degree of sequence 
similarity. Neurotrophins are small homodimeric polypeptides that are 
composed of 120 amino acid residues (McDonald et al. 1991) and signal 
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through the tyrosine kinase (Trk) family of receptors. Each neurotrophin signals 
through a particular high-affinity receptor, with NGF, NT-6, and NT-7 signaling 
through the TrkA receptor, BDNF and NT-4 sharing the TrkB receptor, and NT-
3 signaling through the TrkC receptor. In addition to these specific high-affinity 
receptors, all of the neurotrophins can signal through the promiscuous low-
affinity nerve growth factor receptor p75. One primary mechanism of action of 
the neurotrophins is their ability to regulate the survival of neurons and their 
axonal projections through regulation of their expression in the target tissue 
(Levi-Montalcini & Angeletti 1968; Lindsay 1988). The target tissue produces a 
certain level of neurotrophic factors that allow for survival of a finite density of 
axons and axon terminals. An overabundance of axons and terminals are 
produced during development; however, precise combinations and levels of 
neurotrophic factor expression allows for the survival of the strongest 
connections to the target tissue, while the remaining weaker innervation is 
pruned (Sanes & Lichtman 1999; Reichardt 2006; Johnson et al., 2007).  
One neurotrophic factor of particular importance is BDNF. It has many 
functions, which include its well-known role in development as a growth and 
survival factor, but it has also been shown to function as a neurotransmitter 
and a neuromodulator, as BDNF has the ability to modulate other 
neurotransmitters or act as a neurotransmitter itself. A well-known role for 
BDNF is emerging as a mediator of synaptic modifications through activity-
dependent mechanisms (Caleo et al., 2000; Pezet et al., 2002; Kuczewski et 
al., 2009; Tyler & Pozzo-Miller 2010; Huang et al., 2012). For example, 
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application of BDNF resulted in an increase in synaptic vesicles in excitatory 
presynaptic terminals on dendritic spines in the CA1 region of the 
hippocampus. The frequency of AMPA receptor-mediated excitatory 
postsynaptic potentials (EPSPs) in CA1 neurons in the hippocampus also 
increased upon BDNF exposure (Tyler & Pozzo-Miller 2010). In addition, 
Zhang & Poo (2002) showed an increase in acetylcholine (ACh) 
neurotransmitter secretion when BDNF was applied to the presynaptic axon. 
The ACh potentiation was associated with an increase in [Ca2+]i in the 
axon.  Also, BDNF and its TrkB receptor are involved in the plasticity of 
synaptic connections involved with learning and memory, as mice 
heterozygous for the BDNF gene have impaired long-term potentiation (LTP) 
(Korte et al., 1995).  
In addition to the well-known roles of BDNF in development and learning 
and memory, BDNF is also becoming increasingly implicated as a hormone-
like satiety factor important for feeding behavior and energy balance. Removal 
of BDNF genetically has repeatedly shown hyperphagia and obesity (Lyons et 
al., 1999; Kernie et al., 2000; Rios et al., 2001; Xu et al., 2003; Coppola & 
Tessarollo 2004; Fox & Byerly 2004; Unger et al., 2007; Camerino et al., 2012; 
Liao et al., 2012; Fox et al., 2013). The first report of a potential role for BDNF 
in the regulation of food intake and body weight was accidental, as researchers 
noticed attenuated weight gain in rats that were administered BDNF to test the 
role of BDNF on the function of presynaptic cholinergic hippocampal neurons 
(Lapchak & Hefti 1992; Vanevski & Xu 2013).  Global-heterozygous BDNF KO 
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(BDNF +/-) mice were initially used as a genetic model to study the contribution 
of BDNF to intracellular regulatory pathways that control development and 
influence LTP. These BDNF +/- mice showed increased body weight, 
increased adipocyte density, and they were also insulin and leptin resistant, 
suggesting the mice were obese and diabetic (Lyons et al., 1999; Kernie et al., 
2000). Infusion of BDNF or NT-4 into the third ventricle reversed the obesity in 
these mice and their body weights reverted to wt body weight. After this initial 
accidental discovery of a role for BDNF in regulation of body homeostasis, 
many other studies repeated these findings and expanded upon them. As a 
result, many genetic and pharmacological approaches have consistently found 
that removal of BDNF results in hyperphagia and obesity (Rios et al., 2001; Xu 
et al., 2003; Fox & Byerly 2004; Unger et al., 2007; Liao et al., 2012) and 
infusion of BDNF or TrkB both centrally and peripherally have consistently 
reduced food intake and body weight gain in mice and rats (Pelleymounter et 
al., 1995; Bariohay et al., 2009; Toriya et al., 2010; Spaeth et al., 2012), 
indicating BDNF is emerging as an important mediator of food intake and body 
weight regulation.  
BDNF and Vagal Sensory Innervation 
The majority of vagal sensory neurons depend on BDNF for survival, as 
60% of neurons in the nodose ganglion are lost in global homozygous BDNF 
KO mice, compared to 41% and 43% losses in NT-3 and NT-4 KO mice, 
respectively (Erickson et al., 1996; ElShamy & Ernfors 1997). BDNF is widely 
distributed throughout the brain, in both neurons and glia. However, it is also 
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expressed at high levels in peripheral tissues that are innervated by vagal 
afferents in both embryonic and adult stages of development. Peripheral 
organs with high BDNF mRNA and protein levels are composed of smooth 
muscle layers, including the stomach, small intestine, large intestine, blood 
vessels and epithelial tissues. In fact, the lungs, heart, stomach, duodenum, 
colon, liver, and pancreas all have higher protein BDNF levels than the brain in 
mice at 2 months of age (Lommatzsch et al., 1999). In addition, the receptor for 
BDNF, TrkB, is also expressed in the nodose ganglion and in the enteric 
neurons of the GI tract (Zhuo & Helke 1996), indicating that BDNF can bind to 
and interact with its receptor on vagal afferent terminals to effect a response in 
GI tissues.  However, importantly, neither TrkB nor p75 are present in the 
smooth muscle itself (Lommatzsch et al., 1999). This indicates BDNF cannot 
bind to its receptors to mediate a response in the GI smooth muscle. 
BDNF expression is initiated in GI tissues innervated by vagal afferents 
in embryonic development, when vagal afferents begin to reach their target 
destinations in the GI tract, indicating that BDNF may be necessary for the 
proper development of vagal afferents into the GI tract. The nodose ganglion 
begins to develop between embryonic day (E) 10-E12 (Rinaman & Levitt 1993; 
ElShamy & Ernfors 1997), and initiation of BDNF expression in the embryonic 
GI tract begins to occur at E12 (Fox et al., 2013). Vagal sensory fibers are first 
observed extending into the embryonic gut at approximately E12 (Murphy & 
Fox 2007) while efferent preganglionic fibers arrive in the GI tract at E13 (Sang 
& Young 1998; Rinaman & Levitt 1993). Precursors of sensory and motor vagal 
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nerve terminals begin to develop in the GI tract between E15-E16.5 and have 
reached a mature pattern between postnatal day (P) 8-P10 (Swithers et al., 
2002; Murphy & Fox 2007). As stated before, BDNF is important for the 
survival of vagal sensory neurons (ElShamy & Ernfors 1997). Consistent with a 
role for BDNF in the development of vagal GI afferents, Murphy & Fox (2010) 
showed mice lacking both copies of BDNF had disrupted vagal afferent 
innervation at P0, with a 50% decrease in IGLE density in the stomach 
compared to wild type mice.  
In addition to its role in the development of the gut and the vagal 
afferents innervating it, BDNF may also be important for the function of vagal 
sensory innervation to mechanoreceptors in the GI tract. For example, Carroll 
et al. (1998) showed slowly-adapting mechanoreceptors (SAMs) innervating 
the skin in juvenile BDNF KO mice had impaired neuronal responses, as these 
mice demonstrated decreased mean afferent impulses that were caused by a 
reduction in mechanical sensitivity. Since a majority of vagal afferents 
innervating the smooth muscle of the GI tract important for feeding are also 
SAMs, it is possible the function of vagal afferents that signal back to the brain 
regarding the nutritional status of the GI tract would also be altered by loss of 
BDNF-like mechanoreceptors in the skin. 
Rationale and Hypotheses 
Based on the concomitant spatial and temporal pattern of BDNF 
expression and development of vagal afferents extending into the GI tract, in 
this project, I hypothesized GI BDNF is necessary for the development of vagal 
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afferent innervation in the GI tract, which would subsequently affect ingestive 
behavior. This hypothesis was tested using a genetic approach, since the use 
of transgenic animals to knock out the function of the BDNF gene in a tissue-
specific manner allows for deconstruction of how GI BDNF contributes to the 
development of vagal afferents in the smooth muscle of the GI tract and how 
this potentially impacts feeding behavior. Additionally, because BDNF is found 
throughout the brain and periphery, including the nodose ganglion and CNS 
sites important for the regulation of energy balance, it is important to determine 
the contribution of GI BDNF in the smooth muscle to these processes. 
Targeting BDNF knockout to the smooth muscle allows for 
determination of the impact of BDNF on the development of IGLEs, as these 
vagal afferent mechanoreceptors are located in the smooth muscle layer of the 
GI tract wall. In this project, both BDNF alleles are removed from the smooth 
muscle in order to determine the effect of GI BDNF on the development of the 
vagus nerve and how it contributes to feeding behavior. Mice with a targeted 
knockout of BDNF to the smooth muscle should theoretically have BDNF 
removed from only the smooth muscle with BDNF remaining present in all 
other tissues. 
 Because BDNF is hypothesized to be necessary for the development of 
GI vagal afferents, I predicted loss of GI BDNF would lead to a decrease in 
vagal afferent innervation in the GI tract in the mutant mice. The decrease in 
vagal sensory innervation of the GI tract would result in decreased IGLE 
density in GI organs such as the stomach and intestine. Loss of BDNF from the 
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smooth muscle would also lead to a decrease in vagal afferent fibers and 
bundles innervating the GI tract. IGLEs in the stomach and intestine could be 
decreased through several different ways: they may fail to survive, axons 
projecting outward from the nodose ganglion may fail to reach their final target 
destinations in the GI tract, or the neurons and/or terminals may fail to 
differentiate as a result of BDNF deficiency in GI smooth muscle.  
Just as the density of vagal afferents is hypothesized to be altered due 
to loss of GI BDNF, function of vagal afferents in the GI tract could also be 
disrupted by smooth muscle-specific removal of BDNF. Vagal afferent function 
could be affected indirectly through developmental changes, which could 
subsequently lead to changes in vagal signaling, or the development of vagal 
afferents could remain intact, and function itself could be directly affected by 
BDNF. Furthermore, even if no differences in density emerge, then it is 
predicted that there could still be changes in function, because it has previously 
been shown that although mechanoreceptors in the skin did not have any 
morphological disruptions due to BDNF KO, they did show significantly 
decreased mechanical sensitivity (Carroll et al., 1998). As mechanoreceptors in 
the skin have similar mechanosensitive properties to IGLEs in the GI tract, 
negative vagal feedback signaling from the gut to the brain could be altered in 
mice missing BDNF from the smooth muscle. 
Because I am predicting loss of BDNF from the smooth muscle leads to 
a decrease in IGLE density and/or function in the GI tract, I also predicted 
feeding behavior of the animals would subsequently be altered. Changes in 
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feeding behavior were studied through meal pattern and microstructure 
analyses, since these analyses serve as functional assays to test if there are 
changes in food ingestion that could be associated with changes in vagal 
function. This is important because any changes in meal patterns or meal 
microstructure help pinpoint mechanisms underlying any potential changes in 
food intake. For example, ingestion of larger meals may result from a lack of 
negative feedback signaling. Therefore, I predicted mutant mice missing GI 
BDNF would demonstrate increased meal size. 
I also predicted BDNF smooth muscle knockout mice will not show any 
changes in total food intake or body weight, based on previous reports of the 
role of the vagus in regulation of food intake and body weight, as selective 
vagal deafferentations have repeatedly shown short-term changes in food 
intake but not long-term changes in total food intake that would impact body 
weight (Schwartz et al., 1999; Fox et al., 2001; Berthoud 2008; Fox 2013). For 
example, short term changes in food intake could occur in the mutant mice 
which would indicate alterations in vagal satiation feedback signaling, such as 
increased meal size. However, other compensatory changes could occur such 
that the mice ultimately maintain normal daily food intake and a stable, wild-
type like body weight. This has been previously shown in other studies that 
have employed genetic and SDA manipulations and more specifically, 
neurotrophin transgenic mice, in order to study feeding patterns (Schwartz et 
al., 1999; Kelly et al., 2000; Fox et. al, 2001a; Chi et al., 2004; Powley et al., 
2005; Fox et al., 2013).  
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An additional benefit of knocking out BDNF to study the role of the 
vagus is the ability to also separate out the sensory and motor components of 
vagal innervation to the GI tract. Although both vagal afferents and efferents 
are important for proper regulation of digestion, disentangling their respective 
roles has been difficult. This genetic approach is a sensory-specific 
manipulation, in contrast to surgical methods such as vagotomies, which 
eliminate or damage motor innervation in addition to sensory (Fox 2013). 
Deletion of BDNF from the smooth muscle selectively targets sensory vagal 
innervation, because Jones et al. (1994) showed BDNF is important for the 
survival and differentiation of sensory neurons, but is not essential for 
development of motor neurons. For example, there were no differences in 
neuron number between wild type and global homozygous BDNF KO mice 
(BDNF -/-) in several populations of motor neurons, including the DMV. 
However, in almost every sensory neuron population examined, BDNF -/- mice 
showed significant neuron loss at P15. These included the trigeminal, 
geniculate, vestibular and petrosal-nodose ganglia (Jones et al., 1994). In fact, 
the petrosal-nodose complex showed a 44% loss of neurons in BDNF -/- mice 
compared to controls (Jones et al., 1994). Additionally, BDNF -/- mice showed 
normal development of efferent innervation and myenteric neurons while 
sensory terminals in the GI tract showed a significant 50% loss (Murphy & Fox 
2010). Therefore, in the GI tract, BDNF appears to selectively support the 
survival of  vagal afferent innervation. 
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Complete knockout of BDNF results in perinatal lethality, so an 
approach that bypasses the tissues responsible for the lethal defects in 
respiratory function must be utilized in order to understand the function of this 
protein in adulthood (Erickson et al., 1996; Balkowiec & Katz 1998; Katz 2005). 
Therefore, this project utilized the cre-lox system to target removal of BDNF 
from the smooth muscle. The fatal respiratory defect observed in global 













To generate a knockout of BDNF that is specific to the smooth muscle, 
the cre-lox system was used (Figure 1). In order to successfully employ the 
cre-lox strategy to remove BDNF from the smooth muscle, the following 
breeding strategy was utilized (Figure 2): First, SM22αcre/cre (also called 
transgelincre; Tg (TagIn-cre) 1Her/J) mice were obtained from Jackson 
Laboratories (cat no. 004746; Bar Harbor, ME). These are transgenic mice that 
express the enzyme cre recombinase only in smooth muscle. The strain was 
generated and maintained on a mixed background of 129S5/SvEvBrd, C57BL6 
and SJL mice. Cre efficiency in these SM22αcre/cre mice was previously reported 
to be 100% recombination in the stomach, and 90% in the intestine (Lepore et 
al., 2005). These mice were then mated with floxed BDNF mice: these animals 
have the coding region of the BDNF gene surrounded by cre recombinase 
target sites called loxP sites (BDNF lox/lox). Cre recombinase specifically 
recognizes loxP sites and has been shown to effectively mediate the excision 
of DNA located between loxP sites. These matings (SM22αcre/cre; BDNF+/+ x 
SM22α+/+; BDNFlox/lox) result in all of the offspring being double heterozygotic 
transgenic mice needed for the next round of mating (SMcre/+ ; BDNF +/lox). 
22 
 
These mice are then mated among themselves (SMcre/+ ; BDNF +/lox x SMcre/+ ; 
BDNF +/lox) to produce the experimental groups of mice. This breeding strategy 
results in six different genotypic possibilities (Fig 2). These six genotypes  
generated are:  
 
 
(1) SM22α+/+; BDNF +/+ (wild type).  
-These mice are the primary control group and are not missing 
any BDNF from the smooth muscle. These mice have normal 
levels of BDNF, with neither allele floxed, nor do they have the cre 
transgene. 
 
(2) SM22αcre/+; BDNF+/+ (cre only) 
-These mice do not have any floxed BDNF alleles; although they 
do have the cre recombinase transgene. However, because there 
are no loxP sites present, cre cannot bind, and therefore, no 
knockout will occur.  
 
(3) SM22α+/+; BDNFlox/lox (double lox) 
-These mice have both BDNF alleles floxed, but because they are 
missing the cre transgene, no DNA should be recombined 
between the lox sites, and all of the BDNF in the animal should 
remain present. It has been shown that insertion of lox P sites do 




(4) SM22α+/+; BDNF+/lox (single lox) 
-These mice have one floxed BDNF allele and do not have the cre 
transgene, therefore, just as with the animals in (3), will not have 
BDNF KO.  
 
(5) SM22αcre/+; BDNF+/lox   (BDNF SM +/-) 
-These mice are targeted heterozygotes, because while they have 
the cre transgene, they only have one floxed BDNF allele, so 
therefore approximately 50% of BDNF will be removed from the 
smooth muscle. 
 
(6) SM22αcre/+; BDNFlox/lox  (BDNF SM -/-) 
-These mice are the primary group for comparison to wt mice. 
They are targeted homozygotes that are missing both copies of 
BDNF from the smooth muscle and should have normal BDNF  
levels in the rest of the body. 
 
 
 The breeding strategy utilized in this study resulted in the generation of 
a total of 400 mice. A total of 20 Generation 1 mice (10 SM22αcre/cre; BDNF+/+ 
and 10 SM22α+/+; BDNFlox/lox) from the two founder strains maintained in the 
lab were used to breed Generation 2. These 10 matings of Generation 1 
resulted in 74 Generation 2 pups. A total of 26 of these Generation 2 mice (13 
males and 13 females) of the double heterozygous  mice (SMcre/+ ; BDNF +/lox x 
24 
 
SMcre/+ ; BDNF +/lox) were bred together to generate a total of 306 Generation 3 
pups.  
 The percentages of pups obtained from each genotype are similar to 
predicted ratios according to Mendelian genetics. The distribution and number  
of pups generated from each genotype in Generation 3 is as follows: 
 
 
wild-type: 26 pups, 8.5% 
cre only: 58 pups, 18.95% 
double lox: 22 pups, 7.19% 
single lox: 48 pups, 15.69% 
BDNF SM +/-: 101 pups, 33.01% 
BDNF SM -/-: 51 pups, 16.66%  
 
 
 We have previously identified sites of SM22α cre-mediated 
recombination using Rosa26 and BDNFlox-lacZ reporter mice (Fox & Biddinger 
2012; Fox et al., 2013). These mice allow for visualization of the KO location in 
the GI tract using a LacZ reporter. Rosa 26 reporter mice contain a floxed stop 
sequence in front of the LacZ gene. When cre recombinase binds to the lox 
sites, the stop sequence is removed and this allows for transcription of the β-
galactosidase gene which can then be stained with X-gal. The BDNFlox-lacZ 
reporter mice allow for visualization of the KO by a method similar to that for 
the Rosa26 reporter mice.  These experiments showed SM22α cre-mediated 
recombination occurs in the smooth muscle of blood vessels and mesentery in 
the GI tract at the same developmental age as GI afferents begin developing 
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into the GI tract (E12), making the SM22α cre suitable promoter to effectively 
KO BDNF from the smooth muscle.  
All animals were genotyped at weaning using tail tips. Primer sequences 
used for genotyping were: BD3: 5’ GGC TTC ATG CAA CCG AAG TAT G 3’, 
BD ln1: 5’ TGG GAT TGT GTT TCT GGT GAC 3’, Cre 800: 5’ GCT GCC ACG 
ACC AAG TGA CAG CAA TG 3’, Cre 1200: 5’ GCT GCC ACG ACC AAG TGA 
CAG CAA TG 3’.  Amplified genomic DNA was visualized by gel 
electrophoresis on a 2% agarose gel with ethidium bromide added. All mice 
were maintained on a 12:12 hr light:dark cycle at 23°C with ad libitum access 
to a chow diet (Rodent Diet 5001; Purina, St. Louis, MO) and tap water, except 
during meal pattern and meal microstructure data collection periods. All 
procedures were conducted in accordance with the American Association for 
Accreditation of Laboratory Animal Care guidelines and were approved by the 
Purdue University Animal Care and Use Committee.  
RNA Extraction and cDNA Synthesis 
BDNF mRNA was extracted in order to verify the specificity of the KO of 
BDNF from smooth muscle organs. Wild type (n = 10) and BDNF SM -/- (n = 
10) mice were sacrificed by cervical dislocation at 3-4 month of age. Prior work 
clearly showed BDNF was removed from GI tissues using the SM22α cre 
promoter at embryonic ages (Fox & Biddinger 2012; Fox et al., 2013), however 
it is unclear if cre-mediated recombination also occurs in the adult.  Therefore, 
mice were sacrificed at 3-4 months old for RNA extraction in order to coincide 
with the anatomical and behavioral experiments in this study. Hypothalamus, 
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prefrontal cortex, whole ventral stomach, and the first 2 cm of duodenum were 
dissected and homogenized in Trizol (Invitrogen, Carlsbad, CA). Next, RNA 
was extracted by first separating the aqueous phase containing the RNA from 
the DNA-containing organic layer using choloroform. Then, the RNA was 
precipitated out with isopropyl alcohol and washed in 75% ethanol. The RNA 
concentration was determined from the optical density at 260 nm absorbance, 
and the purity of the RNA was calculated by the ratio of the 260 nm/280 nm 
absorbance.  Each 1 µg RNA sample was incubated with DNase1 (Invitrogen) 
to remove genomic DNA and first-strand cDNA was synthesized using the 
Maxima enzyme mix (Thermo Scientific, Barrington, IL) in 20 µl PCR reactions. 
The PCR protocol for cDNA synthesis is as follows: 25°C for 10 min, 50°C for 
15 min, and then the reaction was terminated by heating at 85°C for 5 min. 
This product was used in further RT-PCR and QPCR experiments to visualize 
and quantify BDNF mRNA expression (see below).  
Qualitative Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) 
To visualize BDNF mRNA, qualitative RT-PCR was performed. After 
cDNA synthesis and DNase treatment, 2 µL cDNA was amplified using the Taq 
PCRx DNA polymerase kit (Invitrogen). The PCR protocol used to amplify the 
cDNA was: 94°C for 3 min and 35 cycles with 94°C for 45 s, 55°C for 30 s, and 
72°C for 90 s followed by 72°C for 10 min. Primer sequences employed were 
(Kawakami et al., 2002, Zermeno et al., 2009):  BDNF forward:  5' GAA GAG 
CTG CTG GAT GAG GAC 3', BDNF reverse:  5' TTC AGT TGG CCT TTT GAT 
ACC 3', β-actin forward:  5' TGG TGG GTA TGG GTC AGA AGG ACT C 3',  
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β-actin reverse:  5' CAT GGC TGG GGT GTT GAA GGT CTC A 3'. β-actin 
cDNA from each sample was also amplified to assess the integrity of the 
isolated total RNA and reverse transcriptase was omitted in negative controls 
after Dnase treatment to confirm the removal of genomic DNA. Total PCR 
products were visualized by gel electrophoresis on a 2% agarose gel with 
ethidium bromide added.  
Quantitative Reverse Transcriptase Polymerase Chain Reaction (QPCR) 
In order to quantify the extent of BDNF mRNA loss from the smooth 
muscle, quantitative RT-PCR was performed. Amplification of 1µg cDNA from 
the first-strand reaction was performed in triplicate using the following PCR 
protocol:  95oC for 10 min and 45 cycles with 95oC for 30 s, 60oC for 30 s, and 
72oC for 30 s (Unger et al., 2007; Cordeira et al., 2010). Primer sequences 
employed were (Cordeira et al., 2010): BDNF forward: 5’ GAA AGT CCC GGT 
ATC CAA AG 3’, BDNF reverse: 5’ CCA GCC AAT TCT CTT TTT 3’, β-actin 
forward: 5’ GGC TGT ATT CCCC TCC ATC G 3’, β-actin reverse: 5’ CCA GTT 
GGT AAC AAT GCC ATG T 3’. For each primer set, melt curve analysis was 
used to determine the appropriate concentration mRNA and to confirm the 
absence of primer dimers.  These curves were created using serial dilutions 
and the PCR efficiency was calculated (Cordeira et al., 2010; Fox et al. 2013). 
All primers were optimized such that the correlation coefficient was 0.99–1.0 
and the PCR efficiency was 95–100%. Real-time PCR amplification was 





Male and female mice were weighed once a week on the same day 
each week, except when mice were weighed daily during meal pattern and 
microstructure experiments. Body weight measurements of all genotypes 
generated were initiated at weaning, when the animals were 3 weeks of age, 
until meal pattern collection began at 3-4 months of age. Sample sizes 
included in the long-term body weight measurements are: males: wt (n = 7), cre 
only (n = 10), SM22α+/+; single lox (n = 4), double lox (n = 6), BDNF SM +/- (n = 
10), BDNF SM -/- (n = 10). Females: wt (n = 7), cre only (n = 10), single lox (n = 
10), double lox (n = 2), BDNF SM +/- (n = 10), BDNF SM -/- (n = 10). Some of 
these same animals were included in the body composition and meal pattern 
analyses in order to be as efficient as possible with the transgenic mice. Mice 
in the body weight measurements described above that were also included in 
the body composition and meal pattern analyses were 7 male and 6 female wt 
mice and 7 male and 8 female BDNF SM -/- mice.  
Body Composition 
Fat and lean body masses were determined in wt (n = 13; 7 males, 6 
females) and BDNF SM -/- (n = 15; 7 males, 8 females) mice using an 
EchoMRI whole-body composition analyzer (EchoMRI-900, Echo Medical 
Systems, LLC, Houston, TX) in live mice without anesthesia (Taicher et al., 
2003; Tinsley et al., 2004). This quantitative nuclear magnetic resonance 
instrument was utilized to obtain precise measurements of body composition 
parameters, including total body fat, lean mass, body fluids, and total body 
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water.  Fat and lean mass were calculated as total grams and also as a 
percent of total body mass. Body composition was measured on the day before 
meal pattern testing was initiated, prior to fasting, when the animals were 3-4 
months of age. All of the mice used in the body composition analysis were the 
same mice used for the meal pattern analysis experiment. 
Tracer Injections Into the Nodose Ganglion 
To visualize vagal afferent innervation and vagal nerve terminals in the 
GI tract of BDNF SM -/- mice (n = 9; 5 males, 4 females) and controls (n = 12; 
4 males, 8 females), the nerve tracer horseradish peroxidase conjugated to 
wheatgerm agglutinin (WGA-HRP) was injected into the nodose ganglion. This 
method was utilized because to date it is the only tracer that labels nearly the 
entire population of sensory vagal axons and their terminal endings (Mesulam 
1978; Fox et al., 2000; Wang & Powley 2000). Mice were anesthetized with 
intraperitoneal (i.p.) injections of a ketamine hydrochloride (Ketaset, Fort 
Dodge IA, 33. 34 mg/mL) - xylazine (Anased, Lloyd Laboratories, Shenandoah, 
IA, 100 mg/mL) mixture. The left nodose ganglion was exposed and WGA-HRP 
(Vector Laboratories Inc., Burlingame, CA; 0.5 µL, 4%) was pressure-injected 
(PicoSpritzer Iid; General Valve Corporation, Fairfield, NJ; 40 p.s.i., 4 msec) 
into the ganglion using a glass micropipette (inner diameter, 25 mm). 
Tissue Processing 
Twenty-twenty two hours after nodose ganglion injection, mice were 
anesthetized using Brevital sodium (JHP Pharmaceuticals, Rochester, MI, 
500mg/mL) or ketamine (Ketaset, Fort Dodge IA, 33. 34 mg/mL) - xylazine 
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(Anased, Lloyd Laboratories, Shenandoah, IA, 100 mg/mL) mixture. Mice were 
perfused for 5-10 minutes with warm 0.9% saline until the liver cleared, and 
then fixed with 3% paraformaldehyde (PFA)/0.75% gluteraldehyde at 4mL/min. 
The dorsal and ventral halves of the stomach and the first 8 cm of the intestine 
were processed as wholemounts. The smooth muscle and mucosal layers of 
the GI tract wall were separated by sharp dissection using Dumont #7 forceps. 
The tissues were processed using tetramethylbenzidine according to the 
protocol by Mesulam (1978) and mounted on gelatin coated slides. Next, the 
tissues were flattened by placing weights on a slide covering the tissue for 30 
min. They were then air-dried overnight and cleared with xylene the following 
day. The slides were then coverslipped using D.P.X. mounting medium (Sigma 
Aldrich, St. Louis, MO).  
IGLE Quantification 
The IGLEs in the ventral stomach and first 8 cm of duodenum in BDNF 
SM -/- mutants and controls were quantified using a previously characterized 
method. This quantification method was first utilized by Wang & Powley (2000) 
in the rat, and was later modified for use in the mouse by Fox and colleagues 
(2000). First, the area of the stomach was determined. Then, a sampling grid 
that adjusts for the area of the stomach was used to locate sites in the stomach 
and intestine to be sampled and quantified. Next, a 1 X 1 cm2  counting grid 
that consists of one hundred 1 mm2 squares was placed in the ocular of the 
microscope. This allows for quantification of IGLEs at the calculated sampling 
sites. Criteria for IGLE identification were as previously determined: an IGLE 
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must consist of a laminar aggregate of fine terminal puncta within the neuropil 
of a myenteric ganglion, and must cover all or part of the myenteric ganglion 
(Rodrigo et al., 1975; Rodrigo et al., 1982; Neuhuber 1987; Fox et al., 2000). 
Counting of IGLEs was conducted at 100X magnification. Occasionally, 
200X magnification was used to verify the presence of IGLEs. However, once 
an IGLE was identified at 200X, counting was done at 100X. Because it can be 
difficult to distinguish individual IGLEs, the squares of the counting grid that 
contained IGLEs were counted. This method of quantification resulted in 48 
different areas of each stomach half sampled, which accounts for 
approximately 13% of the total stomach area.  IGLE density is defined as the 
number of squares of the sampling and counting grid containing IGLE terminal 
puncta per mm2. Density of IGLEs in the stomach was also analyzed by 
stomach compartment. Stomach compartments were determined by dividing 
the width of the stomach into 8 equidistant columns based on the sampling 
sites calculated from the area of the tissue, and closely approximating how 
many vertical columns constituted each compartment. IGLEs in the three 
columns nearest the fundus of the stomach were counted as the forestomach, 
the middle three columns as the corpus, and the two columns nearest the 
pyloric sphincter as the antrum. The nerve tracer and method of quantification 
employed in this study do not clearly distinguish terminal size and number, 
each of which contributes to terminal density. Potential implications of this are 
discussed in the discussion section. 
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To quantify IGLEs in the duodenum, the same counting grid as 
described above was used. The duodenum was sampled and quantified as 
follows: starting near the anterior end where tissue is intact, the counting grid 
was aligned at one lateral edge of the duodenum and all squares of the 
counting grid containing IGLEs at each sampling site were quantified.  The grid 
was moved sequentially along the entire width of the intestine and squares of 
the grid containing IGLEs were counted at each of the sampling sites. This was 
repeated every 5 mm moving caudally along the length of the first 8 cm of 
duodenum. This method of quantifying IGLEs in the duodenum resulted in 
approximately 80 different sampling sites, resulting in quantification of 
approximately 20% of the total area of the intestine.  
The total area of the stomach, the width of the duodenum at the pyloric 
sphincter, width of the intestine just before the cecum, and the length of the 
intestine did not differ between BDNF SM -/- mice and controls. The area 
sampled in the stomach and intestine also did not differ between BDNF SM -/- 
mice and controls. 
 Wholemounts were not included in the analyses if vagal afferent 
innervation could not be adequately observed. For example, large portions of 
the stomach or intestine with unlabeled labeled fibers indicate an incomplete 
injection. Also, sometimes vagal afferent fibers cannot be visualized due to 
dense artifact that can occur with this method and these cases were also not 
included in the analyses (Mesulam 1978). In this study, 70% of the animals 
injected were included in the analysis (15 controls and 12 mutant animals were 
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injected with WGA-HRP, but 3 controls and 3 BDNF SM -/- mice were dropped,  
resulting in final sample sizes of n=12 for controls and n=9 BDNF SM -/- 
animals). There were no differences in IGLE density between males and 
females; therefore their data were combined. 
Axon Bundle Density Quantification 
In addition to quantification of IGLE density, other aspects of vagal 
innervation were further investigated by quantification of circular and 
longitudinal individual fibers and fiber bundles in the intestine of BDNF SM -/- 
mice (n = 9) and controls (n = 9). A fiber is defined as a single axon that is not 
contained within a vagal fiber bundle. A bundle is defined as two or more axons 
coursing together in parallel and in close apposition. Vagal elements were 
quantified using the same sampling sites as described above for the intestine 
(see IGLE quantification) and magnification (100X). Each time a circular or 
longitudinal axon fiber or axon bundle crossed the top or left sides of the 
squares of the counting grid at each sampling site it was counted. Axons 
crossing the right and bottom sides of the grid were not counted to ensure no 
axons were counted twice as the squares at each sampling site were analyzed 
for axon crossings. This process was repeated at each sampling site as the 
grid was moved along the intestine. 
Bundle Diameter 
The diameters of circular and longitudinal fiber bundles in the intestine 
of BDNF SM -/- mice and controls were measured and quantified. This was 
done using the same sampling sites and magnification (100X) used for 
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quantification of IGLE density in the intestine and vagal axon bundle density as 
described above. Axon bundles were measured by placing a micrometer scale 
onto the same counting grid in the ocular of the microscope as described 
above, projecting a ruler onto the field of view of each sampling site. Every 
axon bundle that crossed the top and left sides of each square of the counting 
grid was counted and measured. Bundle diameters were measured to the 
nearest 0.5 µm, as this was the smallest observable diameter bundle using the 
WGA-HRP nerve tracer. Because the bundles were measured to the nearest 
0.5 µm, they were grouped into 0.5 µm-diameter bins.   
Nodose Ganglion Cell Counts 
Right and left nodose ganglia were removed from wt (n = 9) and BDNF 
SM -/- mice (n = 14). After dissection, the ganglia were postfixed in 4% PFA for 
48 hr and then transferred to 10% buffered formalin for a minimum of 7 days. 
The ganglia were then embedded in paraffin, sectioned at a thickness of 10 µm 
and stained with cresyl violet. The first section that contained substantial 
stained neurons was counted, followed by every subsequent tenth section 
containing stained neurons that spanned the entire ganglion. Counting was 
done at 200X magnification to ensure only neurons that contained a clearly 
identified nucleolus were counted. The raw numbers obtained were then 
multiplied by the total number of sections per ganglion to ensure accurate 




Meal Pattern Analysis 
Wt (n = 13) and BDNF SM -/- mice (n = 15) at 3–4 months of age were 
housed individually in plastic cages equipped with computerized pellet 
dispensers (Coulbourn Instruments, Allentown, PA) for collection and analysis 
of eating patterns. Each automated pellet dispenser was equipped with infrared 
photobeam sensors that detected beam breaks every 100 ms. When a mouse 
removed a pellet, the beam break was detected and another pellet was 
dispensed. Raw data was analyzed using Graphic State software (v2.0; 
Coulbourn Instruments). Meal patterns were collected using a balanced pellet 
diet (20 mg dustless 380 precision pellets, Bio-Serv, Frenchtown, NJ), which is 
similar to chow. The macronutrient composition of the pellet diet used in the 
automated feeding machines is 22% protein, 66% carbohydrate, and 12% fat, 
with a caloric density of 3.623 kcal/g. This is comparable to the chow diet which 
is composed of 28% protein, 60% carbohydrate, and 12% fat, with a caloric 
density of 3.04 kcal/g. To become acclimated to the test cages and diet before 
the experiment, mice were adapted to the test room and cages for a minimum 
of 1 week before the start of meal pattern collection. During that week, animals 
received three limited pre-exposures to the test diet, each consisting of 10 of 
the Bio-Serv precision pellets, to prevent neophobia at the start of testing. All 
animals used in the experiment ate all 10 pellets during each pre-exposure. 
Intake patterns were monitored 18 h each day and animals were fasted the 
remaining 6 h, during which time cage maintenance was performed and mice 
were weighed. Each daily session began at the start of the dark phase of the 
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light cycle (lights out at 5:00 pm) and extended 6 h into the light phase, and 
meal pattern data were collected for 22 consecutive days. Mice of each 
genotype were tested in parallel to control for any inadvertent variations in the 
testing conditions. 
Meal Criteria 
Meal initiation was defined as a minimum of seven pellet removals with 
a minimum of 20 min between responses. Once a meal was initiated, meal 
termination was defined as the onset of a 20-min interval with no food intake. 
The criteria for meal onset (time interval between pellet removals and number 
of pellet removals) were determined by systematically varying them and 
examining the effect on meal number (Fox & Byerly 2004). These data were 
used to identify the range of criteria that exhibited the greatest stability in 
estimates of meal numbers, and the specific set of criteria chosen was drawn 
from the middle of this range. These criteria were applied to the raw data using 
the Graphic State software to identify the times of onset and termination of 
each meal, which were used to calculate several meal parameters. These were 
considered to be good estimates based on the observation that mice 
consumed all or almost all of each pellet, as evidenced by the minute amount 
of spillage present on cage floors.  
Meal Microstructure 
The first meal of each daily test session (defined as spontaneous food 
intake during the first 30 min after mice gained access to the food at the start of 
the session) was subjected to microstructural analysis to characterize changes 
37 
 
in food intake rate over the course of this first meal after six hours of food 
deprivation (Davis, 1998; Fox & Byerly 2004). Meal microstructure data was 
collected at the same time and using the same animals as in the meal pattern 
analysis. Initial intake rate and changes in this rate across the 30-min feeding 
session were estimated by determining the amount of food consumed during 
each minute of the first 30 min of food intake. Analysis of meal microstructure 
allows for deconstruction of the initial or oropharyngeal and postingestive 
contributions to food intake which drive ingestive behavior. The initial rate of 
food intake is influenced by taste or other oropharyngeal factors that represent 
motivational or hedonic controls of food intake. The latter part of the meal 
represents the rate of decrease in intake rate, which is mainly influenced by 
postingestive controls of food intake, such as vagal negative feedback signals 
activated by the accumulation of food in the GI tract as the animals become 
satiated. 
Statistical Analysis and Graphical Display of Data 
Changes in BDNF mRNA levels between controls and BDNF SM -/- 
mice were determined by comparing changes in the constitutively expressed 
housekeeping gene, β-actin, and BDNF.  This was done using the Livak and 
Schmittgen method (2001). Briefly, the difference in gene expression between 
BDNF and β-actin in the tissues was calculated and then compared using one-
way analysis of variance (ANOVA). Levels of BDNF mRNA normalized to β-
actin in controls were set at 100%. Animals with the cre transgene only (no 
floxed BDNF) or the lox transgene only (no cre) did not differ from wt mice in 
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any variable tested, and were therefore combined with wt in some cases for 
more efficient animal use. Values are presented as means ± SEM (standard 
error of the mean). Body weight and body composition in BDNF SM -/- mice 
mutants and controls were tested using one-way ANOVA. Differences in IGLE 
density, and vagal fibers and bundles between controls and BDNF SM -/- mice 
were determined using one-way ANOVA. Nodose ganglion counts were 
compared between genotypes using one-way ANOVA. All counting in this 
study was performed by the same experimenter (J.E.B.) and done blind to 
genotype. Meal pattern variables were tested in wt and BDNF SM -/- mice 
using repeated-measures ANOVA across days 5-22. Meal microstructure was 
analyzed using TongueTwister software (v1.45, Tallahassee, FL). Food intake 
between wt and BDNF SM -/- mice during meal microstructure analysis was 
tested using one-way ANOVA for individual time points and repeated-
measures ANOVA over multiple days. Statistics were tested using Statistica 
software (v6.0, StatSoft, Tulsa, OK). P-values less than 0.05 were considered 
significant. Graphs were constructed with GraphPad Prism (v4.0, GraphPad 
Software, Inc.) software. Figure layouts were organized using Photoshop (v6.0 
Adobe Sytems, Mountain View, CA). Photoshop was also used to adjust 













Verification of BDNF SM -/- KO Mice 
In order to verify BDNF KO in the smooth muscle, two different types of 
RT-PCR were performed. Qualitative RT-PCR was first performed to verify 
RNA integrity. Quantitative RT-PCR was performed to quantify the extent to 
which BDNF RNA was decreased in the stomach and intestine in BDNF SM -/- 
mice compared to controls. Qualitative RT-PCR showed bands of BDNF from 
the hypothalamus, prefrontal cortex, ventral stomach and first 2 cm of 
duodenum at the expected 332 bp. Bands of β-actin mRNA from the 
hypothalamus, prefrontal cortex, ventral stomach and first 2 cm of duodenum 
were observed at the expected location of 266 bp (Zermeno et al., 2009).There 
were no bands visible in PCR products made from mRNA that had not been 
reverse transcribed, indicating no DNA contamination. 
Quantitative RT-PCR showed trends toward decreased BDNF mRNA 
levels in the ventral stomach and first 2 cm of duodenum in BDNF SM -/- mice 
compared to controls, as shown in Figure 3.  Levels of BDNF mRNA were 
decreased by 82% in the intestine of BDNF SM -/- mutants compared to 
controls, and decreased by 54% in the ventral stomach of BDNF SM -/- mice 
compared to controls. Levels of BDNF mRNA in hypothalamus and cortex were 
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similar in mutants and controls, which implies the KO is specific to the GI tract, 
as high levels of BDNF remain in the CNS. The decrease in BDNF mRNA 
levels in BDNF SM -/- mice compared to controls appeared to be greatest in 
the intestine, indicating the intestine as the primary site of cre-mediated 
recombination, although there was also a substantial decrease in BDNF mRNA 
levels in the stomach. Relative % of BDNF mRNA levels in BDNF SM -/- 
mutant mice compared to controls in each tissue were: 79.87 ±12.43 % in the 
hypothalamus (p = 0.310), 85.02 ± 36.28% in the prefrontal cortex (p = 0.369), 
45.99 ± 24.55% in the ventral stomach (p = 0.294), and 17.95 ± 13.21% in the 
first 2 cm of intestine (p = 0.117). 
Body Weight 
The breeding strategy employed to generate BDNF SM -/- mice and the 
relevant control groups resulted in six different genotypes. The body weights of 
males of all genotypes are shown in Figure 4A and females of all genotypes 
are shown in Figure 4B.  Body weights are shown from weaning at 3 weeks of 
age until adulthood at 4 months of age. All animals showed a normal, wt-like 
body weight and typical growth curves. There were no differences in body 
weight between any of the genotypes in either males or females at any age. 
Importantly, mice expressing either the cre transgene or lox transgene alone 
showed no body weight phenotype, suggesting the transgenes themselves 




Density of Vagal Afferent Innervation in the Stomach and Intestine 
IGLE Morphology and Density in the Stomach 
Vagal afferent innervation and IGLEs were labeled in the stomach and 
intestine of control and BDNF SM -/- mice in order to determine the role of 
BDNF on the development of sensory innervation and nerve endings in the 
smooth muscle. IGLES observed in the stomach displayed the characteristic 
pattern of innervation as shown in both genotypes in Figure 5. Vagal afferent 
fibers and bundles terminate in groups of IGLEs, which can be seen as 
aggregates of fine terminal puncta. Images of IGLEs in the stomach of control 
mice are shown in Figure 5A, while BDNF SM -/- are shown in Figure 5B. 
Morphology of IGLEs in both the stomach of controls and BDNF SM -/- mice 
appeared to be normal. Shape, size, and distribution of IGLEs appeared to be 
normal in the forestomach, corpus, and antrum compartments of the stomach 
in both groups of mice, and also appeared very similar to those observed in 
other studies (Fox et al., 2000; Fox et al., 2001a; Powley et al., 2005) and other 
strains of mice (Fox et al., 2000). 
IGLE density was quantified as the average IGLE density of the ventral 
wall (Fig 6A) and also in each of the stomach compartments of the ventral wall 
(Fig 6B). Similar IGLE densities were observed in each stomach compartment 
(Fig 6B). There were no differences detected in total IGLE density between any 
of the genotypes in the stomach (Fig 6A: control:  3.23 ± 0.46 IGLEs/mm2; 
BDNF SM -/-: 4.01 ± 0.79 IGLEs /mm2; p > 0.05), or between any of the 
stomach compartments (Fig 6B: control forestomach: 2.84 ± 0.49 IGLEs / mm2; 
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BDNF SM -/- forestomach: 3.68 ± 1.05 IGLEs /mm2; control corpus: 3.58 ± 0.58 
IGLEs / mm2; BDNF SM -/- corpus: 4.60 ± 0.54 IGLEs /mm2; control antrum: 
3.33 ± 0.93 IGLEs / mm2; BDNF SM -/- antrum: 3.71 ± 1.10 IGLEs /mm2; p > 
0.05 for all comparisons). These values are similar to those observed in 
previous studies (Fox et al., 2001a). Although nonsignificant, there was a trend 
toward increased IGLE density in BDNF SM -/- mutants compared to controls. 
This trend was observed across all three stomach compartments. 
IGLE Morphology and Density in the Duodenum 
Like IGLE morphology in the stomach, control and BDNF SM -/- mice 
appeared to have qualitatively normal looking IGLEs, as shown in Figure 7. 
Morphology of IGLEs in the duodenum representative of controls are 
demonstrated in Fig 7A, while representative BDNF SM -/- IGLEs are shown in 
Fig 7B. Shape of IGLEs appeared to be normal in the duodenum in both 
groups of mice, and also appeared very similar to those observed in other 
studies (Fox et al., 2000; Fox et al., 2001a; Powley et al., 2005) and other 
strains of mice (Fox et al., 2000). Vagal afferent fibers and bundles can be 
seen giving rise to the IGLE nerve terminal endings. The innervation pattern of 
axons seen here was previously described (Fox et al., 2000) as a lattice 
pattern formed by the perpendicular branching of bundles that follows the 
organization of the myenteric plexus. IGLEs of both genotypes displayed this 
characteristic pattern of innervation and morphology in the duodenum. 
Although IGLEs in the duodenum appeared to have a normal 
morphology in control and BDNF SM -/- mice, surprisingly, there was an 
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increase in IGLE density in BDNF SM -/- mice compared to controls in the 
intestine. This increase in IGLE density of mutants can be observed in Figure 
7, which shows IGLE density at high-magnification in the duodenum of control 
(Fig 7A) and BDNF SM -/- mice (Fig 7B). Figure 8 also shows an increase in 
IGLE density in the duodenum of BDNF SM -/- mutant mice (Fig 8B) compared 
to controls (Fig 8A), shown as photomontages composed of approximately 50 
images each at a decreased magnification.  
The increase in IGLE density in the duodenum of BDNF SM -/- mice 
compared to controls was statistically significant at a 40% increase, as shown 
in Figure 9 (IGLE density for total 0-8 cm: control:  5.61 ± 0.71 IGLEs/mm2; 
BDNF SM -/-: 7.78 ± 0.72 IGLEs/mm2; p <0.05). This finding was unexpected, 
as the original hypothesis was that knocking out a growth factor would lead to a 
decrease in neuron outgrowth and vagal afferent endings as shown in other 
studies (Fox et al., 2001a; Raab et al. 2003; Murphy & Fox 2010) and more 
specifically, that BDNF SM -/- mice would show a decrease in IGLE density. 
The increase in IGLE density in the BDNF SM -/- mice appears to be 
consistent across the entire 0-8 cm duodenum, as both the 0-4 and 4-8 
portions of the intestine showed this increase, however only the total average 
IGLE density (0-8 cm) described above was statistically significant (0-4 cm: 
control:  5.36 ± 0.81 IGLEs/mm2; BDNF SM -/-: 7.76 ± 0.80 IGLEs/mm2, p = 
0.053; 4-8 cm: control:  5.35 ± 0.64 IGLEs/mm2; BDNF SM -/-: 7.33 ± 0.82 
IGLEs/mm2, p = 0.071). The density of IGLEs determined across the first 8 cm 
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of the duodenum in this study represents a novel finding, as there are nearly 
identical IGLE densities in the first 4 cm (0-4 cm) as in the 2nd 4 cm (4-8 cm).  
Vagal Element Density 
In order to further investigate the contribution of BDNF to the 
development of vagal sensory innervation of the GI tract, several vagal 
elements were quantified in control and BDNF SM -/- mice: the density of 
individual longitudinal axon fibers, longitudinal axon bundles, individual circular 
axon fibers, and circular axon bundles was determined. Figure 10 shows the 
density of these vagal elements across the entire 0-8 cm of duodenum 
sampled (A), the first 4 cm of duodenum sampled (B), and the next 4-8 cm of 
duodenum sampled (C). See Table 1 for values ± SEM. Consistent with 
previous studies, the first 4 cm of duodenum displayed much higher density of 
vagal afferent innervation compared to more caudal parts of the intestine 
(Berthoud et al., 1997; Fox et al., 2000; Fox et al., 2001a). The first 4 cm of 
duodenum showed increased innervation compared to the 4-8 cm duodenum 
in all vagal elements quantified except individual circular fibers, although there 
was a trend towards increased 0-4 circular fiber density compared to 4-8 cm 
circular fiber density in both genotypes. In general, there tended to be 
increased axon bundle density in both longitudinal and circular orientations 
compared to individual free axon density across both genotypes. Additionally, 
there tended to be increased longitudinal fibers and bundles compared to 
circular fibers and bundles, as has been seen in prior reports (Fox et al, 2000). 
These trends were observed at all parts of the duodenum sampled. There were 
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no statistically significant differences in the density of any of the vagal elements 
quantified between BDNF SM -/- mice and controls, at any part of the 
duodenum sampled. However, there was a trend toward increased axon 
bundle density in BDNF SM -/- mice in both the longitudinal and circular 
orientations compared to controls, across all parts of the duodenum. 
Interestingly, the percent increases in longitudinal and circular bundles in 
BDNF SM -/- mice compared to controls in the total (BDNF SM -/- longitudinal 
bundle increase: 36%; BDNF SM -/- circular bundle increase: 39%), 0-4 (BDNF 
SM -/- longitudinal bundle increase: 35%; BDNF SM -/- circular bundle 
increase: 37%), and 4-8 (BDNF SM -/- longitudinal bundle increase: 69%; 
BDNF SM -/- circular bundle increase: 44%) cm of duodenum are almost 
identical in the total and 0-4 cm duodenum, and increased in the 4-8 cm 
duodenum. However, although the percent increase in longitudinal bundles is 
larger in BDNF SM -/- mice compared to controls in the 4-8 cm duodenum, 
there is a trend toward increased average longitudinal bundle density 
compared to circular bundle density in the 0-8 and 0-4 cm duodenum. 
Quantification of individual longitudinal and circular fibers revealed almost 
identical densities in BDNF SM -/- and control mice (Table 1). Percent change 
of individual axon fibers in BDNF SM -/- mice compared to controls: 2.7% 
decrease in total 0-8 cm longitudinal fibers; 15% increase in total 0-8 cm 
circular fibers; 0.6 % decrease in 0-4 cm longitudinal fibers; 7% increase in 0-4 
cm circular fibers; 0.7% increase in 4-8 longitudinal fibers; 38% increase in 4-8 




In order to further refine the contribution of vagal bundle innervation in 
the intestine, diameter of axon bundles were measured to the nearest 0.5 µm 
in both the longitudinal and circular orientations in control and BDNF SM -/- 
mice. Figure 11 and Table 2 show axon bundle diameter measured in controls 
and BDNF SM -/- mice in the longitudinal orientation (A) and the circular 
orientation (B). In general, there were increased numbers of longitudinal axon 
bundles compared to circular bundles in both wt and BDNF SM -/- mice.  The 
largest-diameter bundles (4.5 – 6.0 µm), were rarely observed in either the 
longitudinal and circular orientations in either genotype. In control mice, there 
was an inverse dose-response function observed, such that there were 
decreased axon bundles observed at each subsequent increase in diameter. 
This was observed in both longitudinal and circular bundles of the control mice. 
This same inverted dose-response function was generally observed in BDNF 
SM -/- mice as well, except for the number of longitudinal and circular bundles 
in the 1.5 – 2.0 µm diameter range.  In the smallest diameter longitudinal 
bundles observed, the 0.5 – 1.0 µm diameter range, there were no differences 
between control and BDNF SM -/- mice (Figure 11A). However, at the 1.5 – 2.0 
µm diameter range, BDNF SM -/- mice showed a greater number of 
longitudinal bundles compared to control mice (p < 0.05). In the 2.5 – 3.0 µm 
diameter range, there were no differences in longitudinal bundle number 
between control and BDNF SM -/- mice, although there was a near significant 
(p = 0.071) trend for BDNF SM -/- mice to show an increased number of 
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longitudinal axon bundles. At the 3.5 – 4.0 µm and 4.5 – 5.0 µm diameter 
ranges, BDNF SM -/- mice showed a statistically significant increase in the 
number of longitudinal bundles compared to control mice (p < 0.05).  There 
were very few longitudinal axon bundles of the largest diameter observed, 5.5 
– 6.0 µm, either in control or BDNF SM -/- mice, and there were no differences 
in axon bundle density at these large diameters (Table 2). 
 The increase in number of bundles at larger diameters observed in 
BDNF SM -/- mice compared to controls was specific to axon bundles in the 
longitudinal orientation, as there were no differences observed in number of 
bundles at any diameter in the circular orientation between BDNF SM -/- mice 
and controls (Figure 11B; Table 2). There was a trend toward increased 
circular bundle number in BDNF SM -/- mice compared to controls in all but the 
5.5 – 6.0 µm diameter range bundles; however this trend was not statistically 
significant at any diameter measured. 
Nodose Ganglion Counts 
Vagal sensory neuron number was quantified in control and BDNF SM -/- mice. 
This was done in order to aid in distinguishing if the increases shown in IGLE 
density and larger-diameter axon bundle number were due to increased neuron 
survival or increased axon branching. Increased IGLE density in BDNF SM -/- 
mice could result from an increase in the proliferation or survival of vagal 
sensory neurons in these animals. If there is an increase in the number of 
neurons, then the axonal projections from these neurons could result in an 
increase in the number of terminal endings in the intestine. Alternatively, the 
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density of vagal sensory neurons may remain normal in the mutants, but the 
axons that give rise to IGLEs could demonstrate increased branching, which 
could also result in an increase in IGLE density in the intestine. Figure 12 
shows cresyl-violet stained nodose ganglion neurons in control (A) and BDNF 
SM -/- mice (B) and quantification of nodose ganglion neurons in control and 
BDNF SM -/- mice, including the left and right sides, and the total nodose 
ganglion neuron numbers summed from both sides (C). Consistent with the 
increased vagal innervation in the GI tract, there was a statistically significant 
47% increase in total nodose ganglion number in BDNF SM -/- mice compared 
to controls (Fig 12C: control: 3615.45 ± 315.90; BDNF SM -/- : 5324.16 ± 
487.64, p = 0.012, as shown in Table 3). The increase in vagal sensory neuron 
number suggests increased survival of these neurons. This increase in total 
neuron number was achieved through a trend in increased neuron number in 
BDNF SM -/- mice compared to controls in the left side (p = 0.129) and a 
significant increase in the right side (p = 0.017; Table 3).  
Food Intake, Body Weight and Body Composition During  
Meal Pattern Collection 
Food Intake 
Daily food intake was measured at the time of meal pattern collection, in 
young adulthood at 3-4 months of age on a balanced pellet diet. Daily food 
intake is shown in Figure 13A. There were no differences in daily food intake 
between the genotypes (wt: 3.19 ± 0.11 g; BDNF SM -/-: 2.96 ± 0.10 g). The 
food intake observed in this study (~ 3.0 g/day) is consistent with many other 
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studies and is the typical amount of chow a normal, wt mouse eats daily 
(Kernie et al., 2000; Fox et al., 2001a; Biddinger & Fox 2010; Krashes et al., 
2013).  There were also no differences in daily food intake between males or 
females, therefore their data were combined (Table 4).  
Body Weight 
Daily body weights observed on days 1-22 of meal pattern collection are 
shown in Figure 13B. The body weights observed during meal pattern 
collection are consistent with those shown in the long-term body weight curves 
in Figure 4.  There were no differences in body weight at any time point 
between any of the genotypes during meal pattern collection.  
Body Composition 
Body composition was determined the day prior to meal pattern 
collection, before fasting. Body composition was analyzed as the total grams of 
body fat, total grams of lean mass, body fat as a percent of total body mass, 
and lean mass as a percent of body mass, in both males and females. Figure 
14 shows total fat mass and total lean mass in male (A) and female (B) BDNF 
SM -/- mutants and control mice. There were no differences between the 
genotypes in either fat mass or lean mass, in either males or females. There 
were also no differences observed in fat mass or lean mass in males and 
females, although males tended to have slightly more lean mass compared to 
females.  Figure 15 shows fat mass and lean mass calculated as a percent of 
total body mass in male (A) and female (B) BDNF SM -/- mutants and controls. 
There were no differences between any of the genotypes in either fat mass or 
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lean mass as a percent of total body mass, in either males or females. There 
were also no differences observed in the percent of fat or lean mass in males 
and females, although females tended to have slightly more fat mass as a 
percent of their body mass compared to males.   
Meal Pattern and Meal Microstructure Analyses 
Meal Patterns 
Analysis of meal patterns is a behavioral assay that can be used to 
study any potential changes in the function of vagal afferent signaling. If vagal 
satiation signaling is impaired, this could be detected by changes in meal 
patterning. There were no differences in meal pattern parameters between 
males and females (Table 4); therefore their meal pattern data were combined. 
Changes in several meal pattern parameters were observed that are consistent 
with increased satiation and satiety in BDNF SM -/- mutants compared to 
controls. Significant decreases in both total and average meal duration was 
observed in BDNF SM -/- mice compared to wt mice (Figure 16A and B). Total 
meal duration (Fig 16A), which is the total time spent eating throughout the 18 
hr meal collection period was significantly decreased in the mutants compared 
to controls (wt: 174.83 ± 23.7 min; BDNF SM -/-: 93.44 ± 22.08 min; p < 0.05). 
Additionally, the average meal duration (Fig 16B), which is the total time spent 
eating throughout the 18 hr meal collection period divided by the total number 
of meals taken during this time period was also significantly decreased in 
mutant BDNF SM -/- mice compared to wt mice (wt: 22.07 ± 3.65 min; BDNF 
SM -/-: 9.10 ± 3.94 min; p < 0.05). The decreases observed in meal duration 
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translate to a 47% decrease in the total meal duration and a 60% decrease in 
the average meal duration, respectively, in BDNF SM -/- mice compared to wt.  
 This significant decrease in meal duration contributed to a 20% 
decrease in meal size in BDNF SM -/- mice compared to wt mice, as shown in 
Figure 16C (wt: 0.359 ± 0.018 g; BDNF SM -/-: 0.286 ± 0.017 g; p < 0.05). The 
decrease in meal duration combined with the decrease is meal size is 
consistent with the interpretation that food is more satiating to BDNF SM -/- 
mice than wt, which could be due to an increase in vagal satiation signaling 
through increased negative feedback from the gut to the brain.  
In addition to meal pattern changes in BDNF SM -/- mice that are 
associated with increased satiation, there were also changes in the feeding 
behavior of the mutants that are consistent with increased satiety. The 
intermeal interval (IMI) is the time spent between meals not eating. The IMI can 
be used as an indicator of satiety, as the mouse’s state of satiety affects the 
length of time between meals. There was a significant 20% increase in total IMI 
in BDNF SM -/- mice compared to wt, and although not statistically significant, 
the average IMI was trending toward an increase in BDNF SM -/- mice 
compared to wt mice (total IMI p < 0.05; average IMI p = 0.090). Figure 17 
shows total (A) wt: 596.94 ± 37.15 min; BDNF SM -/-: 715.56 ± 34.59 min and 
average (B) wt: 62.50 ± 2.77 min; BDNF SM -/-: 68.55 ± 2.58 min IMI values. 
BDNF SM -/- mice also demonstrated an 27% increase in satiety ratio 
compared to control mice, as shown in Figure 17C (wt: 193.2 ± 3.83 min/g; 
BDNF SM -/-: 244.63 ± 4.27 min/g; p < 0.05). The satiety ratio is a calculated 
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meal pattern parameter derived through the ratio of the IMI and the preceding 
meal size, which provides an estimate of how effective a given amount of food 
is at producing satiety.  
 Although BDNF SM -/- mice showed decreased meal duration and 
decreased meal size, which suggest increased satiation, and increased IMI 
and satiety ratio which suggest increased satiety, the mutant mice did not 
demonstrate any changes in overall food intake. Therefore, these short-term 
changes in feeding behavior were compensated for by other changes in meal 
pattern parameters to maintain normal food intake. This occurred through an 
increased eating rate and a trend toward an increase in meal frequency in 
mutant mice, which are depicted in Figure 18. The BDNF SM -/- mutants 
showed a significant 40% increase in intake rate (Fig. 18A, wt: 1.36 ± 0.23 
g/min; BDNF SM -/-: 2.04 ± 0.21 g/min; p < 0.05). BDNF SM -/- mice also 
compensated for increased satiation and satiety with a trend toward increased 
meal number compared to wt mice (Fig 18B). They ate approximately one 
more meal during the 18 hr meal pattern collection period than wt mice (wt: 
9.53 ± 0.46 meals; BDNF SM -/-: 10.81 ± 0.43 meals. Together, the meal 
pattern data are consistent with the known role of vagal afferents in the short-
term control of food intake, as there were changes in the feeding behavior of 
BDNF SM -/- mice indicative of increased satiation, but no long-term change in 





Like meal patterns, meal microstructure analysis can also be used as a 
functional assay to observe any changes in the feeding behavior of the animals 
that could be associated with any changes in vagal signaling. The initial rate 
and changes in intake rate over the first 30 minutes of food intake provides a 
way to discriminate between oropharyngeal and postingestive contributions to 
eating (Davis 1998). Rate of food intake across the first 30 min meal after a 6 
hr fast and averaged across days 5-22 are shown in Figure 19. This is depicted 
by each minute across the 30 min time period (A) and averaged across the 
entire 30 min (inset, B). Both wt and BDNF SM -/- mice show a very high initial 
intake rate as shown in minute 1 due to mild food deprivation (Fig 19A). During 
this first meal, the initial rate of food intake was similar in mutants and controls. 
As expected, there is a rapid decay of food intake rate as the animals of both 
genotypes start to become satiated during minutes 2-5 (Fig 19A). However, 
starting at minute 6, the BDNF SM -/- mice begin to show increased 
suppression of food intake compared to the controls. At around minute 20, 
BDNF SM -/- begin to initiate their second eating bout of the night, which is 
slightly before controls. During the next minute they start to decrease their food 
intake again, before wt mice become satiated. These time frames are 
consistent with the average meal duration as shown in Figure 16B during meal 
patterns.  
The rate of food intake across minutes 6-30 is shown in Figure 20. This 
is depicted as the food intake rate per minute (A) and also as the average food 
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intake across minutes 6-30 (B).  Consistent with vagal afferent mediation of 
increased satiation in mutants, the subsequent sustained intake rate across 
minutes 6-30 was reduced by 40% in mutants compared to control mice (wt: 
0.0957 ± 0.000362 g/min; BDNF SM -/- : 0.0581 ± 0.000362 g/min; p < 0.05).  
However, also consistent with increased vagal satiation signaling, the mutant 
mice compensated for this increase such that there was no difference in overall 
food intake across the 1st 30 min of feeding between controls and BDNF SM -/- 
mice (Fig 19B, wt: 0.251 ± 0.0032 g/min; BDNF SM -/- : 0.240 ± 0.0037 g/min). 
This compensation was due to small, non-significant trends toward increased 
average food intake during minutes 1 and 2 after the six hour fast in BDNF SM 
-/- mice compared to wt mice (Fig 19A), which resulted in a trend toward the 
overall food intake across min 1-30 to be decreased in BDNF SM -/- mice 












Smooth muscle-specific removal of BDNF resulted in a significant 
increase in vagal innervation of the GI tract compared to controls, which was 
demonstrated by an increase in IGLE density in the intestine and an increase 
in number of larger-diameter longitudinal axon bundles, while IGLEs in the 
stomach displayed normal density. This increase in GI vagal innervation in the 
intestine could be due to increased vagal sensory neuron number. In addition, 
the increased IGLE density in BDNF SM -/- mice was associated with 
increased satiation and satiety that occurred through decreased meal duration 
and meal size, and increased IMI and satiety ratio in BDNF SM -/- mice 
compared to controls. The increases in satiation and satiety in BDNF SM -/- 
mice were compensated for by increased daily feeding rate and a trend toward 
increased meal number to maintain normal food intake. Consistent with the 
increased satiation demonstrated by BDNF SM -/- mice, analysis of meal 
microstructure revealed increased suppression of food intake during the 
postingestive phase of food intake.  
The increase in IGLE density and longitudinal bundles observed in the 
intestine of BDNF SM -/- mice was surprising. It was originally predicted that 
smooth-muscle specific KO of BDNF would result in a decrease of vagal 
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afferent innervation, including decreased density of IGLEs and vagal fibers and 
bundles. There are several reports demonstrating that KO of neurotrophic 
factors leads to decreased mechanoreceptor density in the smooth muscle of 
the GI tract (Fox et al., 2001a; Raab et al., 2003; Murphy & Fox 2010). The 
reverse has also been observed, such that knockin (KI) of NT-4 leads to 
increased IGLE density (Chi et al., 2004). 
Characterization of BDNF SM -/- KO Mice 
Qualitative and quantitative PCR were utilized to verify and quantify the 
extent of the KO in GI tissues of adult BDNF SM -/- mice compared to controls. 
Qualitative PCR verified RNA integrity, indicating the RNA was not degraded. 
Quantitative PCR (QPCR) revealed trends towards decreases in BDNF mRNA 
levels in the ventral stomach (54% decrease) and first 2 cm of the duodenum 
(82% decrease) in BDNF SM -/- mice compared to controls. There was minimal 
BDNF removed in the CNS regions analyzed, as there were only 20 and 15% 
decreases in the hypothalamus and prefrontal cortex, respectively, in BDNF 
SM -/- mutants compared to controls, indicating the BDNF KO is restricted to 
the GI tract.  
Although not statistically significant, BDNF was lost to a greater extent in 
the small intestine than in the stomach in BDNF SM -/- mice. This greater loss 
of BDNF in the intestine compared to the stomach is consistent with previous 
findings from our laboratory. Previous work in our lab provided a 
characterization of the expression of the SM22α promoter crossed to the BDNF 
promoter, essentially allowing for visualization of the BDNF SM -/- KO location 
57 
 
(Fox et al., 2013). The region where two independent events occur is the 
location of the KO: First, the enzyme cre recombinase needs to be present in 
high enough levels to recombine the DNA between the lox sites surrounding 
the BDNF exon. This is determined by the activity of the SM22a promoter in a 
given cell type. Additionally, there also needs to be high enough levels of the 
BDNF promoter activity in order to visualize the LacZ reporter expression that 
becomes activated when cre recombinase removes the BDNF coding 
sequences. These studies showed overlapping expression of the two 
promoters primarily in the smooth muscle of blood vessel walls in the GI tract, 
indicating this as the primary site of the KO. As the same two promoters were 
utilized in the present study, it is likely the location of the KO in the BDNF SM -
/- mice in this study is the same or similar to the previous experiments in the 
Fox et al. (2013) study.    
Although an 82% decrease in BDNF mRNA levels in the intestine of 
BDNF SM -/- mice compared to controls is large, there are several reasons 
why the decrease did not reach statistical significance. The GI tract wall is 
composed of several layers, and the smooth muscle is just one of them. The 
mucosa and myenteric plexus are additional layers of the GI tract wall which 
contain high levels of BDNF (Lommatzsch et al., 1999; Fox 2006; Grider et al., 
2006; Boesmans et al., 2008). It is possible the remaining BDNF in the 
mucosa/lamina propria and myenteric plexus layers obscured the ability to 
detect the difference in BDNF mRNA levels in the smooth muscle layers. In 
embryonic stages of development, there are low levels of BDNF in the mucosa 
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(Fox & Murphy 2008). However, over time the mucosa shows increased levels 
of BDNF expression, and by adulthood there are high levels of BDNF in the 
mucosa (Lommatzsch et al., 1999). Because BDNF mRNA levels were 
measured in adulthood, it is possible BDNF in the mucosa layers of the GI tract 
impeded measurement of BDNF mRNA levels in the smooth muscle layers. 
Measurement of BDNF mRNA levels in BDNF SM -/- embryos, before BDNF 
expression in the mucosa becomes apparent, may show a more clear 
decrease. 
Additionally, because both BDNF alleles were knocked out in the 
smooth muscle using the cre-lox methodology, there is the risk of increased 
variability in cre expression. The cre recombinase enzyme is not expressed 
uniformly in all cell types. A limitation of using cre-lox technology is variability in 
the expression patterns of cre transgenes and recombination efficiency (Chien 
2001; Schmidt-Supprian & Rajewsky 2007). The original report which 
presented the generation of SM22α cre mice reported cre efficiency to range 
between 50-80% (Holtwick et al., 2002). Cre efficiency in the present study is 
likely to be similar. The variability in cre efficiency can in turn create variability 
in the extent of the KO in BDNF SM -/- mice. Although the mean decrease in 
BDNF mRNA levels in BDNF SM -/- mice is 82%, the error is large which limits 
the ability to reveal a statistically significant decrease in BDNF levels in the 
mutants compared to controls.  
The significance of the restriction of the BDNF SM KO to the blood 
vessels and its contribution to the feeding effects as described in the present 
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study is unknown.  Vagal axons grow alongside the blood supply in the GI 
tract, indicating these axons may be the axons primarily impacted in the BDNF 
SM -/- mice. This could potentially impact the satiation and satiety of the 
mutant mice, as they could be more susceptible to GI hormones in the blood 
supply, such as CCK, which could lead to increased satiation in the BDNF SM -
/- mice. However, unpublished results in our laboratory showed expression of 
the BDNF promoter using the LacZ reporter dissipates in the blood vessels 
after birth, while expression remains in the rest of the tissues in adults (Fox, 
unpublished results). This time course and pattern of expression suggests the 
KO is restricted to development, and there are no additional functional changes 
that emerge in adulthood due to BDNF removal from blood vessel walls during 
embryonic development.  
Consistent with the QPCR data showing BDNF was knocked out to the 
greatest extent in the intestine, effects on vagal afferent innervation 
demonstrated by BDNF SM -/- mice appear to be specific to the intestine as 
well, as the IGLEs in the intestine of the mutant mice were increased compared 
to controls, while the IGLEs innervating the stomach displayed normal density.  
As many other visceral organs innervated by vagal afferents are composed of 
smooth muscle, it is highly likely that BDNF was removed from these other 
organs. Therefore, if BDNF is removed from other organs innervated by vagal 
afferents such as the lungs, heart, kidneys, etc., this loss could potentially 
impact feeding behavior of the mice. However, it remains likely that the 
observed changes in feeding behavior are specific to BDNF removal from the 
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GI tract. Although BDNF is important for the development of many organs, 
changes in these organs may not change the feeding behavior of the animals. 
Alterations in vagal innervation and function of the lungs, for example, would 
be unlikely to lead to increased satiation and satiety. In addition, there were no 
changes in body weight or body composition which would suggest the 
development and/or function of other GI or visceral organs was affected by the 
BDNF SM KO.  
Possible Mechanisms Underlying the Effects of Reduced BDNF in the 
Smooth Muscle on Increased Vagal Sensory Innervation 
There are several explanations for why the counterintuitive increase in 
IGLE density and vagal bundles was observed. Increased IGLE density, 
increased number of larger-diameter vagal fiber bundles and increased vagal 
sensory neurons in the nodose ganglion of BDNF SM -/- mice suggests BDNF 
in GI smooth muscle may normally function to suppress survival (or 
proliferation or axon guidance) of vagal GI afferents. A balance of promoting 
and suppressive biological processes is necessary for proper development, 
and it appears BDNF in the smooth muscle is important for suppression of 
IGLE growth or survival. Although it is surprising the removal of a growth factor 
results in an increase in axon diameter and mechanoreceptor density, similar 
effects have been observed in other peripheral nervous systems.  
Increased sympathetic innervation to hair follicles was previously 
demonstrated in homozygous global knockout of BDNF (BDNF -/-) mice 
compared to controls (Rice et al., 1998). Additionally, BDNF -/- mice, at 2 
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weeks of age, which is prior to the lethal respiratory deficit, demonstrated an 
increase in density of mechanoreceptors that innervate Merkel cells in the skin 
(Fundin et al., 1997). Mice deficient in BDNF (BDNF -/-) have also shown an 
increase in the extracellular matrix glycoprotein Reelin. These mice showed 
disorganized organization of cajal-retzius cells with aberrant axon fibers 
entering the cortical plate (Ringstedt et al., 1998). Application of BDNF 
antagonists also led to an increase in regeneration of forepaw 
mechanosensory innervation in the rat after spinal cord deafferentation, 
indicating BDNF has a suppressive effect on mechanosensory primary afferent 
axons (Ramer et al., 2007). As ablation of BDNF has led to increases in 
sensory innervation in other peripheral nervous systems, it is possible a similar 
role for BDNF on the development of vagal sensory innervation to 
mechanoreceptors in the GI tract has been uncovered. 
Although counterintuitive, there are several reasons why the removal of 
a growth factor might lead to an increase in axon growth. As there are several 
processes underlying development, it is unclear what developmental aspects of 
vagal afferent innervation in the smooth-muscle are impacted by BDNF in this 
study. There are several important features of neuronal development that could 
be affected by BDNF. These include the birth or neurogenesis of new neurons, 
the differentiation of totipotent neuronal stem cell precursors into specific cell 
types, neuronal proliferation, axonal outgrowth of new neurons to their final 
target destination, and synapse formation of IGLEs with myenteric neurons. 
Several possible explanations involving these processes are discussed below. 
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Increased Neuron Survival in BDNF SM -/- Mutant Mice 
The increase in vagal sensory neurons in the nodose ganglion observed 
in BDNF SM -/- mice compared to controls suggests there is increased survival 
of these neurons.  An increase in the number of sensory neurons is consistent 
with the increase in longitudinal bundles and IGLE mechanoreceptor density 
found in the intestine of BDNF SM -/- mutants.  As the number of vagal sensory 
neurons increases, it follows that a corresponding net increase in axons would 
result, and subsequently an increase in IGLEs.  
As neurotrophic factors can influence the development of sensory 
neurons and their survival, there is also evidence that neurotrophic factors can 
subsequently influence several additional aspects of sensory innervation 
through alterations in sensory cell density. Elements of sensory innervation that 
can be impacted through alteration of neurotrophic factors and their effects on 
sensory neurons are density and function of sensory receptors in the periphery, 
and number of axon fibers, which can subsequently affect diameter of axon 
bundles. The increase in neuron number demonstrated by BDNF SM -/- mutant 
mice compared to controls is also consistent with the increase in number of 
larger-diameter longitudinal bundles, as these axons are sending longer nerve 
fibers innervating the length of the intestine. These longer fibers to the intestine 
could be responsible for the increase in IGLE density observed. If there is an 
increase in vagal sensory neurons in the nodose ganglion, there may be an 
increase in the axons projecting from these neurons which could result in an 
increase in nerve endings.  
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A direct relationship between sensory neuron number and density of 
peripheral nerve fibers and terminals has been observed (Krimm et al., 2004; 
Fox et al., 2001a; LeMaster et al., 1999; Stuckey et al., 1999; Davis et al., 
1997; Albers et al., 1996; Jhaveri et al., 1996). For example, overexpression of 
NT-3 in the mouse epidermis resulted in an increase in many different cell 
types that innervate this tissue:  these mice displayed increases in dorsal root 
ganglia sensory neurons, trigeminal sensory neurons, and 
sympathetic neurons (Albers et al., 1996). The mutant mice also displayed an 
increased number of the associated peripheral targets for these neurons, which 
are the Merkel cells in the skin, and showed enlargement of touch dome 
mechanoreceptor units and increased density of piloneural circular endings 
(Albers et al., 1996).  
In addition to an increase in IGLE density in BDNF SM -/- mice, these 
mutants also demonstrated an increase in number of larger-diameter 
longitudinal bundles. Growth factors have been shown to impact axon bundle 
diameter in other sensory systems. Artemin, a member of the glial cell line-
derived neurotrophic factor (GDNF) family, has been shown to lead to an 
increase in axon bundle diameter.  Overexpression of artemin in the tongue 
resulted in an increase in dorsal root ganglion (DRG) neurons and increased 
axon bundle diameter of trigeminal sensory afferents (Elitt et al., 2008).  
Overexpression of BDNF in taste cells located in the gustatory 
epithelium of circumvallate papillae results in increased taste bud size  and 
increased gustatory nerve fiber innervation as determined by the expression of 
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the purinergic receptor P2X3 (Nosrat et al., 2012). It appears BDNF in the GI 
smooth muscle modulates the development of IGLEs through a different 
mechanism than NT-3 in the skin and BDNF in taste cells, because BDNF in 
the GI smooth muscle is knocked-out, while NT-3 in the skin and BDNF in taste 
buds are overexpressed. Nevertheless, in many circumstances there seems to 
be a direct relationship between sensory neuron numbers and density of 
peripheral nerve fibers and terminals (Krimm et al., 2004; Fox et al., 2001a; 
LeMaster et al., 1999; Stuckey et al., 1999; Davis et al., 1997; Albers et al., 
1996; Jhaveri et al., 1996).  
Although there was a significant increase in vagal sensory neuron 
number in BDNF SM -/- mutants compared to controls, this difference was only 
significant when both the left and right sides of the nodose ganglia were 
combined. There was a non-statistically significant trend towards increased 
vagal sensory neuron number in mutants on the left side (33% increase) in 
BDNF SM -/- mutant mice. Because there was no statistically significant 
difference in neuron number in the left ganglion, and there was an increase in 
IGLE terminals in the intestine of mutants, there are potentially other factors in 
addition, or alternative to, increased number of vagal sensory neurons that 
contributed to the increase in IGLE density observed in the mutants compared 
to controls. Potential alternative explanations for the increased terminals other 





Increased Branching of Axons in the Intestine of BDNF SM -/- Mice 
Alternatively, the increase in IGLE density and increased number of 
larger-diameter axon bundles in BDNF SM -/- mice compared to controls could 
be due to increased branching of axons in the intestine, rather than, or in 
addition to, the increase in the total number of vagal sensory neurons. This is 
because after an axon reaches its target destination, it arborizes in order to 
innervate different target cells (Carmeliet & Tessier-Levigne 2005). The axon 
terminals direct this arborization of axon fibers through secretion of 
neurotrophic factors. Local gradients of growth factors also regulate the degree 
of axon arborization at the nerve terminal (Diamond et al., 1992; Goodman & 
Shatz 1993; Davies 2000). For example, it has been shown that BDNF and 
NGF can act as target-derived signals to promote branching of sensory axons 
at nerve terminals (Kennedy & Tessier-Lavigne, 1995; Patel et al., 2000; 
Hellard et al., 2004; Gibson & Ma 2011).  
As global BDNF KO mice typically show a loss of sensory neurons, the 
independent roles of BDNF in neuron survival and terminal arborization are 
difficult to distentangle in the KOs. In order to distinguish the role of BDNF in 
sensory neuron survival from sensory target innervation, mice were generated 
with a double deletion of BDNF and the pro-apoptotic protein Bax (Hellard et 
al., 2004). Double deletion of BDNF and Bax allow for separation of these 
independent processes, as the loss of Bax allows for neuron survival, as Bax 
typically promotes apoptosis. Several peripheral sensory ganglia of the double-
mutant bdnf(-/-)bax(-/-) mice, such as the petrosal, nodose, and vestibular 
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ganglia, showed normal numbers of sensory neurons due to the presence of 
Bax. The axons that project from the peripheral sensory ganglia of the bdnf(-/-
)bax(-/-) mice maintained proper axon pathfinding to their targets in the 
periphery; however, the axons failed to properly innervate the terminals and 
arborize, indicating branch elongation and arborization depend on BDNF 
(Hellard et al., 2004). A similar experiment was performed with NGF and 
similar results were reported: ngf -/-; bax -/- double mutant mice also showed 
normal DRG neuron survival and axon pathfinding to the skin but the axons 
also failed to innervate the terminal (Patel et al., 2000). Therefore, because 
neurotrophic factors also regulate axon branching, particularly in the axon 
terminals, in addition to increased neuron survival, there could be increased 
axon branching in BDNF SM -/- mutants that result in increased IGLE density 
in the intestine. However, because the increase in number of axon bundles is 
specific to the longitudinal orientation rather than the circular orientation, it is 
not likely an increase in branching of axons rather than survival of neurons in 
the nodose ganglion is entirely responsible for the increase in IGLE density in 
BDNF SM -/- mice. If an increase in axon branching occurred in BDNF SM -/- 
mice, there would likely be an increase in circular fibers and bundles as well as 
in longitudinal fibers and bundles. Because the increase in number of axon 
bundles is specific to the longitudinal orientation and there is also an increase 
in vagal sensory neurons in the nodose ganglion in BDNF SM -/- mutants, it is 
likely the increase in IGLE density is due at least in part to increased number of 
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axons that project from the increased number of vagal sensory neurons 
contained within the nodose ganglion.  
Decreased Cell Death and Axon Pruning of Vagal Sensory Neurons in 
BDNF SM -/- Mice 
 During development, an excess of neurons are produced which are 
removed later in a process called axon pruning (Luo & Leary 2005; Low & 
Cheng 2006; Gibson & Ma 2011). An overabundance of axons is produced 
early in life in order to ensure the appropriate number and location of axons 
reaches their target destination. The excess neuronal outgrowth is removed 
later. Axon pruning is a common process that is observed in almost every part 
of the developing nervous system. Approximately 50% of developing neurons 
do not survive until adulthood (Oppenheim 1991; Burek & Oppenheim 1996). 
Inputs to the target region that are stronger and tend to maintain their 
connections are reinforced, while weaker connections are more likely to be 
pruned. This is to ensure the most efficient axons remain for optimal neural 
circuit structure and function. Malfunction of axon pruning is one explanation 
for the selective increase in number of longitudinal bundles in BDNF SM -/- 
mice, while density of circular bundles remained similar in mutants and 
controls. It is likely that because an increase in axon density was observed in 
the longitudinal orientation, that the mechanism of proper elimination of long 
axon collaterals was disrupted in BDNF SM -/- mice. As axons that travel 
longer distances are more likely to be pruned (Liu et al., 2005; Low & Cheng 
2006), this makes the long-reaching longitudinal projections from the nodose 
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ganglion to the intestine likely candidates for this pruning process. However, it 
is likely that lack of proper axon pruning occurred in both the longitudinal and 
circular orientations, and contributed to the increase in IGLE density in BDNF 
SM -/- mice, as there was a trend toward an increase in the number of circular 
bundles in the mutant mice, although this was not statistically significant. At the 
level of the mesentery in the GI tract, longitudinal bundles begin to give off 
circular bundles, so it is likely that increased longitudinal bundles also give rise 
to increased circular bundles in BDNF SM -/- mice compared to controls.  
Another alternative explanation for the increase in larger diameter 
longitudinal axon bundles in BDNF SM -/- mice compared to control mice may 
reflect a decrease in bundle fasciculation, and may not necessarily reflect an 
increase in axon density. Semaphorins are axon guidance molecules that react 
to cues in the environment to direct the tip of a growing axon, the growth cone, 
to its appropriate target. Semaphorins primarily act as repulsive guidance cues, 
which are important for restricting axon bundles and their nerve terminals to 
specific regions. The semaphorin 3D (Sema 3D) is expressed in developing 
vagal afferents and is important for fasciculation of vagal bundles (Taniguchi et 
al., 1997). For example, in order to determine the role of Sema 3 on axon 
guidance, Taniguchi et al. (1997) generated mutant mice that lacked Sema 3D. 
These mice showed aberrant axon pathfinding of many peripheral nerves, 
including the vagus. Sema 3D mutants displayed dramatic increased nerve 
thickness and the axons in each nerve were more spread out. In addition, the 
terminals of the accessory and vagus nerves in all mutant mice analyzed were 
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also spread out and occupied a wider area, while the nerve bundles and 
terminals of wt mice were narrowly bundled.  
There are also known interactions between neurotrophins and 
semaphorins, as Sema 3A has been shown to interact with NGF, NT-3, and 
BDNF to induce cell death of DRG neurons dependent on these neurotrophic 
factors (Tuttle & O’Leary 1998; Dontchev & Letourneau 2002; Ben-Zvi et al., 
2006). Therefore, if the decrease of BDNF in BDNF SM -/- mutants also led to 
a disruption in Sema 3 signaling, this interaction could result in an increase of 
vagal sensory neurons and their axon bundles and terminals. If fasciculation of 
vagal afferent bundles was disrupted due to class 3 Sema molecules, the 
bundles could have a larger diameter due to defasciculation, rather than an 
increase in axon density. However, if bundle defasiculation occured in the axon 
bundles of BDNF SM -/- mice, this should be reflected by an increased number 
of individual free axons and axon bundles of all diameters measured, including 
smaller-diameter axon bundles, not just the larger diameter axon bundles as 
demonstrated in this study. Although it is possible there may be a selective 
defasciculation of larger bundles - for example, as the number of axons 
bundled together in an axon increases, they may be less likely to remain tightly 
bundled. However, in general the evidence does not support decreased 
fasciculation of axon bundles in BDNF SM -/- mice.  This is further 
substantiated by images of axon bundles as shown in Figures 7 and 8. Axon 
bundles in BDNF SM -/- mice do not appear to be defasciculated to a greater 
degree than wt mice, although there is an increased number of larger diameter 
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axon bundles in the mutants. Because nerve tracers cannot easily discriminate 
individual fibers within an axon, the diameter of axon bundles has been used 
as a proxy for the number of axons contained within a bundle. It is assumed 
larger diameter axon bundles contain an increased number of individual axon 
fibers.  A method of visualizing fine morphological details such as electron 
microscopy could be used to more clearly delineate individual axon fibers to 
investigate the degree of defasciculation of vagal bundles in the intestine in 
BDNF SM -/- mice. 
Disrupted p75 and TrkA Receptor Signaling in BDNF SM -/- Mice 
A mechanism that could underlie the potential lack of axon pruning that 
could lead to the increase in axon bundles and IGLE density is disrupted 
signaling through the p75 receptor.  All neurotrophins can signal through the 
promiscuous low-affinity p75 receptor, in addition to their ascribed specific 
receptor. The p75 neurotrophin receptor belongs to a family of transmembrane 
molecules which also act as receptors for the tumor necrosis factor family of 
cytokines. Neurotrophin signaling involves both positive and negative events 
through different intracellular signaling pathways triggered by activation of the 
TrkB receptors or p75. The Trk receptors are thought to play a role in positive 
processes, such as cell growth and survival, while the p75 receptor signals 
negative events, such as apoptosis (Chao 1994; Coulson et al., 2008).  
As the p75 receptor signals cell death, the decreased BDNF in the 
BDNF SM -/- mice could lead to decreased binding of BDNF to the p75 
receptor. The lack of binding to p75 could lead to a decrease in cell death 
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necessary for proper development, resulting in an overabundance of neurons, 
and as a result, an increase in axonal projections and nerve terminal endings. 
This notion has been shown before in sympathetic innervation of the 
submandibular salivary gland. Jahad & Kawaja (2005) showed increased 
sympathetic innervation to the submandibular salivary gland in two different 
types of knockout mice. An increase in innervation was demonstrated in p75 -/- 
and p75(-/-)/BDNF-/- double mutants compared to controls.  They suggested 
the lack of p75 receptor expression enhanced the density of these efferent 
fibers in target tissues in the periphery because the BDNF ligand could not bind 
to the receptor to initiate proper cell death processes. This interpretation is a 
potential explanation for the increase in vagal sensory neurons and IGLE 
density observed in this study, although it is possible efferent sympathetic 
fibers to the submandibular salivary gland develop through different 
mechanisms than vagal GI afferents.  
There are several different pathways through which disrupted p75 
signaling could occur. The precursor form of BDNF, proBDNF, is an apoptotic 
ligand that induces cell death in sympathetic neurons (Teng et al., 2005). 
Neurotrophic factors are generally synthesized in an initial precursor form, and 
yield biologically active mature ligands after enzymatic cleavage (Kolbeck et 
al., 1994; Lee et al., 2001). It was initially thought the precursor form of 
neurotrophic factors were not biologically active until cleaved (Huang & 
Reichardt 2001). However, recent evidence suggests precursor forms of 
neurotrophic factors are also biologically active, although through different 
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mechanisms and under different circumstances (Teng et al., 2005; Coulson et 
al., 2008). For example, neuronal cell death is initiated through binding of the 
neurotrophin to the p75 receptor. Then, a transmembrane-linked C-terminal 
fragment (CTF) is generated that contains the cytoplasmic juxtamembrane 
death domain (Chopper domain) to induce cell death. Next, a second cleavage 
event occurs that is mediated by release of the intracellular domain from the 
membrane by γ-secretase, an integral membrane protease, and regulates cell 
death (Coulson et al., 2000). The death signals initiated by binding of 
neurotrophins to the p75 receptor use the downstream cell death machinery 
known as the apoptosome (capase-9/apoptosis protein activating factor) to 
continue the process of apoptosis (Troy et al., 2002; Coulson et al., 2008).  
In addition to disrupted p75 signaling, levels of other Trk receptors could 
also be dysregulated in BDNF SM -/- mice, allowing for increased IGLE density 
in the intestine of BDNF SM -/- mice. For example, BDNF may be primarily 
acting through the TrkB receptor to suppress IGLE innervation in the intestine 
of BDNF SM -/- mice. Others have suggested BDNF suppression of peripheral 
sensory receptors may occur through down regulation of the TrkA receptor 
(Fundin et al., 1997; Wyatt & Davis 1993). Although TrkA is the primary 
receptor for NGF, which is the least abundant neurotrophin in the nodose 
ganglion, there is evidence that supports it having a larger role than previously 
thought (Katz et al., 1990). Katz et al. (1990) reported virtually no vagal 
sensory neurons were present in culture grown for 24 hr without NGF, while 
cultures grown in the presence of NGF showed substantial growth of neurons 
73 
 
from nodose ganglia explants. Wyatt & Davis (1993) found TrkA mRNA levels 
are normally downregulated by BDNF. Therefore, levels of TrkA may not be 
downregulated properly due to loss of BDNF in BDNF SM -/- mice. As neuron 
survival is limited by a finite growth factor concentration, potential upregulation 
of TrkA due to loss of BDNF could increase these defined neurotrophic factor 
levels, resulting in an increase in NGF ligand, or even other neurotrophic 
factors to a lesser extent, for the TrkA receptor, which could lead to increased 
vagal sensory neuron survival which results in increased vagal sensory 
innervation. It has been well established in the neurotrophin literature that 
these molecules have a tremendous capacity for plasticity, as the neurotrophic 
factors interact with each other and/or other receptors in the development of 
peripheral sensory neurons (Davies et al., 1986; Wyatt & Davis 1993; Erickson 
et al., 1996; Fundin et al., 1997; ElShamy & Ernfors 1997; Rice et al., 1998; 
Chen et al., 1999). 
Increased Cell Growth in BDNF SM -/- Mice 
In contrast to BDNF suppression of vagal sensory neurons and IGLE 
development that could occur through a lack of axon pruning and binding to 
p75, there could alternatively be an increase in cell growth in BDNF SM -/- 
mutants. This could occur by an increase in the birth of new neurons. BDNF 
has been implicated in neurogenesis, as administration of BDNF leads to an 
increase in new neurons (Zigova et al., 1998; Pencea et al., 2001; Scharfman 
et al., 2005; Henry et al., 2007). Although BDNF mRNA is disrupted in mutants 
compared to controls, substantial levels of BDNF remain in the mutants. The 
74 
 
remaining BDNF in the BDNF SM -/- mice could upregulate and increase 
neuron proliferation. 
Alternatively, increased neuron numbers in BDNF SM -/- mutants could 
occur through compensation of other neurotrophic factors. Neurotrophins are 
notorious for cooperating with and compensating for each other, as they share 
similar structures and have overlapping targets (Kolbeck et al., 1994; Lindsay 
1996; Huang & Reichardt 2001). Vagal sensory neurons are no exception to 
this general feature of neurotrophins, as BDNF, NT-3, NT-4, and to a lesser 
extent, NGF, all contribute to the survival of vagal sensory neurons. During 
development, BDNF is responsible for the survival of the largest percentage of 
vagal sensory neurons, compared with NT-3 or NT-4 (Erickson et al., 1996; 
ElShamy & Ernfors 1997). Studies utilizing genetic single and double 
knockouts of neurotrophins have helped in distinguishing the independent and 
cooperative roles of the neurotrophins. For example, and as stated previously 
in the introduction, BDNF is responsible for the survival of 60% of vagal 
sensory neurons in the nodose ganglion and 41% of vagal sensory neurons 
are dependent on NT-3 for survival (ElShamy & Ernfors 1997). However, 
double mutant mice with both BDNF and NT-3 knockout show a 66% decrease 
in vagal sensory neurons, which is a smaller decrease than expected, based 
on the percent decreases shown by the individual neurotrophin knockouts 
(ElShamy & Ernfors 1997). A near 100% decrease in vagal sensory neuron 
numbers would be predicted if neuron loss were additive in the double mutants. 
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Further bolstering the claim that neurotrophin compensation could lead to 
increased vagal sensory neuron number and axon outgrowth, expression of the 
neurotrophic factors themselves have been shown to increase in the absence 
of a differing neurotrophic factor. For example, protein levels of BDNF were 
increased in the hippocampus and cerebral cortex of NT-3 and NGF knockout 
mice (Kolbeck et al., 1999). It is possible that the loss of BDNF during 
development leads to an increase in NT-3 and/or NT-4 to compensate for the 
BDNF loss, which could result in an overcompensation of neuronal growth.  
Other Mechanisms Potentially Involved in the Effects Observed in BDNF 
SM -/- Mice 
Another developmental process that could be impacted by loss of BDNF 
in the smooth muscle is disrupted axon guidance from the nodose ganglion to 
GI targets. There are several reports implicating BDNF and other neurotrophic 
factors in neuron migration and axon guidance (Kennedy & Tessier-Levigne 
1995; Honma et al. 2002; Markus et al., 2002; Pahnke et al., 2004; Mai et al., 
2009). An increase in migration of cortical interneurons was found to be 
stimulated by BDNF and NT-4 (Polleux et al., 2002). Axon growth cones have 
been shown to respond to extracellular gradients of BDNF, suggesting it has a 
role in axon pathfinding. Although a direct role for BDNF in axon guidance is 
lacking, other neurotrophic factors such as GDNF, artemin and neurturin have 
been shown to play a role in axon guidance cues of enteric, sympathetic and 
parasympathetic axons (Young et al., 2004).  For example, artemin is 
expressed by cells around developing sympathetic ganglia and smooth muscle 
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cells of blood vessels. Sympathetic axons grow towards sources of artemin, 
and contribute to sympathetic axon pathfinding by induction of growth along 
blood vessels in the smooth muscle (Honma et al., 2002; Yan et al., 2003; 
Young et al.,2004). Although neurotrophic factors influence axon guidance, 
axon outgrowth of vagal sensory neurons from the nodose ganglion to their 
final target destination in the GI tract is not likely to be aberrant in this study. 
This is because while vagal axon bundles and IGLEs are greater in number, 
they do appear to reach their appropriate target destinations in the stomach 
and intestine. Consistent with this, overexpression of NGF in the skin of 
transgenic mice led to an increase in dorsal root ganglion neurons and 
significantly more axon fibers, but the organization of the nerve fibers was 
unaltered and they maintained a path to the appropriate targets in the spinal 
cord (Mendelson et al., 1996).  
Alternatively, there may be no differences in neuron migration and axon 
guidance of vagal sensory neurons to the target destination in the GI tract, but 
there may be a change or disruption in the signal for other neurons to migrate 
out of the nodose ganglion during development in BDNF SM -/- mutants. 
Peripheral sensory ganglia are derived from two different embryonic tissues: 
the neural crest and the epibranchial placode. In general, the neural crest gives 
rise to many diverse cell types, such as melanocytes, craniofacial bones, 
cartilage, connective tissue, and cardiac smooth muscle cells, while the 
placode gives rise to neurons of the distal geniculate, petrosal, and nodose 
ganglia (Le Douarin et al., 1986; Zhuo et al., 1997; Crane & Trainor 2006; 
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Minoux & Rijli 2010). The neural crest-derived cells are highly migratory, while 
placode-derived cells do not migrate out. This non-migratory characteristic of 
placode-derived cells makes a disruption in the signal for other neurons to 
migrate out during the development of the nodose ganglion in BDNF SM -/- 
mutants unlikely.  
Future experiments are necessary to delineate whether any of these 
explanations are responsible for the increase in vagal sensory innervation 
observed in the intestine of BDNF SM -/- mutant mice in this study. In order to 
determine if a lack of the appropriate cell death that is required for normal 
developmental processes resulted in an overabundance of vagal sensory 
neurons, a TUNEL assay could be performed. It is hypothesized that the BDNF 
SM -/- mice would show a decrease in apoptosis compared to the control mice 
with normal development of vagal sensory neurons and their terminal endings. 
In contrast, if the increase in neurons within the nodose ganglion in BDNF SM -
/- mice was due to an increase in cell growth processes such as replication, 
proliferation, or differentiation, a bromodeoxyuridine (BrdU) labeling assay 
could be used to identify proliferating cells. BrdU is a synthetic analogue of 
thymidine that is incorporated into proliferating cells, allowing for the detection 
of new cell growth. If the increase in vagal sensory neurons in BDNF SM -/- 
mutants were due to an increase in cell proliferation, there would be an 
increase in BrdU labeled cells in the mutants compared to controls.  
In addition to a TUNEL assay and a BrdU labeling study to separate out 
the contributions of cell death and cell growth, mRNA expression of NT-3 and 
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NT-4 could be quantified in BDNF SM -/- mice and controls. If other 
neurotrophic factors such as NT-3 and NT-4 are overcompensating for the loss 
of BDNF in BDNF SM -/- mice, these mutant mice should show an increase in 
the expression of these genes in the smooth muscle compared to controls. 
This is a likely contributor to the increase in nodose ganglion cells and IGLE 
density demonstrated in BDNF SM -/- mice.  
Increased Vagal Afferent Innervation is Specific to the Intestine 
 The increase in IGLE density in BDNF SM -/- mice appears to be 
specific to the intestine, as IGLE density remained normal in the stomach of 
BDNF SM -/- mice. Consistent with this, the small intestine of BDNF SM -/- 
mice demonstrated the greatest decrease in BDNF mRNA levels out of the 
tissues analyzed (82% decrease), which also included the stomach, prefrontal 
cortex, and hypothalamus. It was somewhat surprising that the increase in 
IGLE density was specific to the intestine in this study, rather than to the 
stomach, as might be expected based on previous reports. It was originally 
thought that neurotrophins organized the development of the GI tract in an 
organ-specific manner:  NT-4 was hypothesized to be primarily responsible for 
the development and survival of IGLEs in the intestine, because NT-4 -/- mice 
demonstrated a 90% decrease in IGLE density in the intestine compared to wt 
mice, while IGLE density in the stomach remained normal (Fox et al., 2001a). 
The esophagus appeared to be primarily dependent on NT-3, as there were 
65% and 40% decreases in IGLE density observed in the esophagus of NT-3 
and TrkC heterozygous mutants, respectively (Raab et al., 2003). Therefore, 
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as the intestine was primarily dependent on NT-4, and the esophagus on NT-3, 
it was assumed the stomach was dependent on BDNF. This notion was 
supported by studies showing BDNF -/- mice had decreased IGLE density in 
the stomach at P0 (Murphy & Fox 2010). However, Murphy & Fox (2010) 
concentrated only on the stomach in development, and did not study the 
effects of BDNF on the development of other GI organs such as the intestine or 
in adulthood.  
 It is possible that because BDNF is responsible for the survival of the 
largest percent of vagal sensory neurons, more than one organ system could 
be impacted by loss of BDNF. Consistent with this, although high expression 
levels of both SM22αcre and BDNF lacZ reporters were present in both the 
stomach and intestine, the extent of the expression of these two promoters was 
greater in the intestine, primarily due to expression of the SM22α promoter 
(Fox et al., 2013). This suggests BDNF is responsible for the survival of vagal 
sensory innervation to the intestine as well as the stomach, and may in fact 
play a larger role in the intestine than the stomach. Fox et al. (2013) showed 
there were no changes in IGLE density in the stomach of mutant mice missing 
one global BDNF allele and one SM22α-targeted BDNF allele, (therefore both 
BDNF alleles were missing from the smooth muscle, and these mice are 
known as “SM22α-BDNF KO” mice). Although there was a decrease in vagal 
sensory neurons in the nodose ganglion in these mutant mice, the decrease 
was to a much lesser degree than predicted.  Based on the number of vagal 
sensory neurons at birth in homozygous global BDNF KO mice (ElShamy & 
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Ernfors 1997), a 35% decrease in vagal sensory neurons was expected in the 
SM22α-BDNF KO mice in the Fox et al. (2013) study. However, surprisingly, 
only a 9% decrease in vagal sensory neurons was observed in SM22α-BDNF 
KO mice compared to controls (Fox et al., 2013). This suggested to us at that 
time there may have been increased survival of vagal sensory neurons in the 
mutants due to the disruption of one BDNF allele in the smooth muscle by the 
utilization of the SM22α promoter, which is similar to the findings of the current 
study, as both BDNF alleles were under the control of the SM22α promoter. 
Therefore, when one BDNF allele is removed from the smooth muscle under 
control of the SM22α promoter, as in the Fox et al. (2013) study, there is a 26% 
increase in vagal sensory neurons. Similarly, in the present study, when both 
BDNF alleles are under the control of the SM22α promoter, there is a 47% 
increase in vagal sensory neurons (~ double the increase in sensory neurons 
observed when one BDNF allele is removed under control of the SM22α 
promoter).  
An alternative explanation for the increase in IGLE density in the 
intestine is the BDNF SM -/- mutation altered the development of the nodose 
ganglion itself. If the development of the nodose was disrupted, the normal 
topographical organization of the neurons contained within the ganglion could 
be altered. Therefore, if the location of neurons that send their projections to 
the gut that terminate in IGLEs is altered within the nodose ganglion, the axons 
and their terminal endings could also have a disorganized pattern. Although it 
appears the increase in IGLEs is specific to the intestine in this study, this 
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could be an indirect consequence of the BDNF SM -/- mutation impacting 
intestine-projecting neurons within the nodose ganglion. This is because 
although the nerve tracer injections of WGA-HRP into the nodose ganglion 
may be consistent across genotypes, if the location of intestine-projecting 
neurons within the ganglion is changed in the mutants, the labeling of different 
populations of neurons that project to visceral organs may be disrupted. 
Although the nerve tracer injections appeared to infiltrate the entire ganglion, 
this alternative interpretation is more likely if WGA-HRP did not reach neurons 
located in some parts of the nodose ganglion. However, disrupted development 
of the nodose ganglion itself is unlikely, as the BDNFlox-lacZ reporter previously 
demonstrated that the BDNF SM KO was primarily concentrated to the 
intestine and portions of the antrum and corpus of the stomach (Fox et al., 
2013).  
As mentioned previously, the nerve tracer utilized in this study does not 
clearly distinguish terminal size and number, each of which contributes to 
terminal density. Therefore, the mechanism underlying the increase in vagal 
sensory innervation remains unclear. BDNF SM -/- mice could have an 
increased number of IGLEs in the intestine which leads to larger aggregates of 
IGLE clusters, which could lead to an increase in vagal afferent signaling to the 
brain due to increased sensory input to the NTS. Alternatively, the mutant mice 
could have normal numbers of IGLEs in the intestine, but the individual IGLEs 
could be larger.  Increased IGLE size could also lead to increased negative 
feedback to the brain due to increased IGLE sensitivity, because the size of 
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each terminal would be increased. Although the neural convergence at the 
NTS would likely be decreased if IGLE size was increased, there would still be 
more action potentials sent to the NTS as a result of increased sensitivity due 
to increased stretch at the larger IGLEs. It is likely both increased terminal 
number and size may play a role in the increased satiation and satiety 
observed in BDNF SM -/- mutants. This is because there is an increase in total 
vagal sensory neurons from both the left and right ganglia, which is consistent 
with a selective increase in longitudinal axon bundle number. Additionally, 
although nonsignificant, there is a trend toward increased circular bundles, 
which would indicate increased axon branching. 
Additional nerve tracers could be employed to get a more clear view of 
how size and number impact the increased IGLE density observed in BDNF 
SM -/- mice compared to controls. For example, the Dextran tracers have been 
shown to clearly delineate fine morphological characteristics of individual 
IGLEs. Dextran tracers are useful to obtain high-definition labeling of vagal 
afferent axons and terminals after injection into the nodose ganglion (Fox et al., 
2001a; Phillips & Powley 2007).  
Pathways / Mechanisms Contributing to Increased Satiation  
and Satiety in BDNF SM -/- Mice 
Deficiency of BDNF in the smooth muscle results in decreased total and 
average meal duration, decreased meal size, increased total IMI and increased 
satiety ratio in BDNF SM -/- mutant mice compared to control wt mice. These 
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changes in the feeding behavior of BDNF SM -/- mice suggest increased 
satiation and satiety occur in the mutant mice compared to controls.  
Decreased meal duration alone does not clearly suggest increased 
satiation, as decreased meal duration could result from an increase in 
postingestive influences of food intake that control satiation, or a decrease in 
motivational and/or oropharyngeal influences of food intake. Likewise, 
oropharyngeal and postingestive controls of food intake combine to produce 
meal size. As the satiety ratio is derived from the ratio of IMI and the preceding 
meal size, it is an estimate of how effective a given amount of food is at 
producing satiety, and not a direct measure of the state of satiety an animal is 
experiencing. The IMI is another meal pattern parameter associated with 
satiety, because the extent to which an animal is experiencing satiety 
influences the time interval until the animal initiates its next meal. However, 
meal size also needs to be considered when determining the extent to which 
the IMI influences satiety (as is taken into account in the calculation of the 
satiety ratio), as differences in meal size also determine the duration of the IMI. 
Meal duration and IMI meal pattern parameters do not change food intake 
themselves; however, meal duration and IMI influence meal size and meal 
number, and it is these meal pattern parameters that influence the actual 
amount of food ingested. As such, each meal pattern parameter alone cannot 
definitely determine any mechanisms underlying changes in food intake. 
However, the meal pattern data, taken together with the meal microstructure 
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data, provides a strong case for increased satiation and satiety in BDNF SM -/- 
mice.  
The meal microstructure data strengthen the interpretation of increased 
satiation and satiety in BDNF SM -/- mice, because there were no changes in 
initial food intake at the start of a meal between mutants and controls. This 
suggests there were no differences in oropharyngeal factors or motivation to 
initiate food intake in controls and BDNF SM -/- mice. However, during the 
latter part of the meal, after the animals start to become satiated at around 
minute 6, the mutants show increased suppression of food intake compared to 
wt mice. This decreased food intake during the latter part of the first daily meal 
in BDNF SM -/- mice corresponds to the postingestive phase of food intake.  It 
is likely there were no changes in palatability to food in BDNF SM -/- mice, as 
there were no changes in food intake during the first couple of minutes after a 6 
hr fast. Therefore, because there were no differences between mutants and 
controls in palatability or motivation to initiate food intake, the decreased meal 
duration, decreased meal size, increased IMI and increased satiety ratio 
suggests increased satiation and satiety in BDNF SM -/- mice. 
Although BDNF SM -/- showed increased satiation and satiety, they 
displayed normal total food intake. Consistent with no change in total food 
intake, there were no changes in body composition or body weight in BDNF 
SM -/- mice. This suggests compensation from other meal pattern parameters 
occurred to result in no net change in food intake or body weight. The BDNF 
SM -/- mutant demonstrated an increased feeding rate and a trend toward 
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increased meal frequency that combined to produce compensation for their 
increased satiation and satiety resulted in no net change in food consumed. 
Feeding rate affects meal duration and IMI, which acts to influence meal size 
and number. Therefore, BDNF SM -/- mice were eating at a faster rate during a 
meal, although the time spent eating during that meal was decreased. They 
also ate one more meal during the 18 hr meal pattern collection period each 
day than control mice. Although meal number was not statistically significantly 
increased in mutants on its own, the combination of the trend toward increased 
meal number and increased feeding rate in mutants resulted in compensation 
for the decreased meal duration and size, and the increased IMI and satiety 
ratio. 
 The changes in feeding behavior observed in BDNF SM -/- mice are 
consistent with alteration of vagal signaling, as short-term controls of food 
intake are primarily under control of vagal regulation, rather than long-term 
controls of food intake (Moran et al., 2001; Berthoud 2008). As BDNF SM -/- 
mice show changes in short-term controls of food intake consistent with 
increased satiation and satiety, and not long term changes in food intake that 
influence body weight, the mutant mice may have increased vagal satiation 
signaling. For example, alterations of vagal innervation and vagal feedback 
signaling have resulted in changes in meal size and duration, both of which are 
also observed in the current study (Ritter & Ladenheim 1985; Walls et al., 
1995; Chavez et al., 1997; Schwartz et al., 1999; Kelly et al., 2000; Fox et al., 
86 
 
2001a; Chi et al., 2004; Abbott et al., 2005; Powley et al., 2005; Chi & Powley 
2007).  
The decrease in food intake observed from minutes 6-30 in the meal 
microstructure analysis is also consistent with a vagal role in the control of food 
intake in BDNF SM -/- mice.  It has been well established that when food is 
accumulating in the gut after ingestion, which occurs during the postingestive 
phase of food intake, satiation signals are sent to the brain through vagal 
afferents (Davis et al., 1975; Kaplan et al., 1992). There were no changes in 
initial food intake rate at the start of the meal, indicating there were no 
differences in the oropharyngeal or taste contribution to food intake. This 
suggests there were no differences between the genotypes in hedonic or 
motivational influence to obtain food. As the vagus is not typically considered to 
regulate hedonic influences of food ingestion, but has an identified role in 
postingestive controls of food intake, this data is consistent with an alteration of 
vagal signaling in BDNF SM -/- mice. 
The increases in satiation and satiety observed in BDNF SM -/- mutants 
could be due to the increased IGLE density. The relationship between IGLE 
density and satiation has been demonstrated previously in mice deficient in 
NT-4, which have a 90% decrease in IGLE density in the duodenum, and also 
showed increased meal duration on a solid pellet diet, and increased meal size 
on an Isocal liquid diet (Fox et al., 2001). The inverse relationship has also 
been demonstrated: Mice with an NT-4 KI showed increased IGLE density in 
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the intestine, and these mice showed increased satiation, which resulted in 
decreased meal size (Chi et al., 2004). 
The changes in ingestive behavior observed in the BDNF SM -/- mice 
could be a result of changes in vagal function, such as increased vagal 
negative feedback signaling to the brain. There are several different processes 
that could be impacted to result in increased vagal negative feedback 
signaling. A potential mechanism of altered vagal signaling could occur through 
maintenance of normal sensory receptor sensitivity, but because there is an 
increased number of sensory terminals and fibers signaling back to the NTS, 
there may be increased vagal satiation signaling in mutant BDNF SM -/- mice.  
The increase in the number of axons could lead to an increase in the 
summation of neuronal inputs to the NTS. Alternatively, increased vagal 
afferent signaling could occur through increased sensitivity of the sensory 
mechanoreceptors themselves, which could result in increased sensitivity to GI 
stimuli such as distention, and could lead to an increased number and/or 
duration of action potentials, increased firing rate, or an altered firing pattern in 
some other way that also results in increased vagal signaling from the intestine 
to the NTS. Daly et al. (2011) demonstrated changes in vagal signaling through 
decreased frequency of baseline neuronal impulses of intestinal afferents by 
whole nerve multiunit extracellular recordings in mice on a high fat diet. Mice 
on a high fat diet showed a 70% decrease in spontaneous afferent discharge 
rate arising from isolated segments of jejunum compared to controls. After 
increased luminal pressure was applied to test the mechanosensitivity of the 
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afferents, the high fat diet-fed mice also showed a reduction in firing frequency. 
It is possible similar effects could be seen in BDNF SM -/- mice, although in the 
opposite direction, as they have increased vagal afferent innervation. 
Alternatively, or in addition to, alterations in development that can lead to 
functional changes in vagal signaling that can impact ingestive behavior, the 
increased satiation and satiety observed in BDNF SM -/- mice compared to 
controls could also occur through direct functional changes in adulthood. 
Increased sensitivity of IGLEs to distention in BDNF SM -/- mice could occur in 
adulthood. Electrophysiological methods should be employed in the future to 
tease apart any changes in vagal function to the observed increases in 
satiation and satiety in BDNF SM -/- mice.  
An alternative explanation for the increases observed in satiation and 
satiety in BDNF SM -/- mice compared to controls rather than the proposed 
explanation of increased vagal afferent innervation in the intestine is because 
BDNF may be necessary for the survival or development of other targets in the 
GI tract. In addition to vagal innervation, there other neural inputs to the 
smooth muscle in the GI tract, such as the sympathetic and enteric nervous 
systems (Young et al., 2004; Fox et al., 2013). It is possible the loss of BDNF 
in BDNF SM -/- mice could impact these other targets in the GI tract and result 
in the changes observed in feeding behavior.  
Sympathetic innervation of the GI tract is a possible candidate to be 
impacted by loss of BDNF from the smooth muscle. However, NGF and NT-3 
are primarily responsible for the development of sympathetic innervation of the 
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GI tract and this innervation is thus not dependent on BDNF for survival 
(Crowley et al., 1994; Albers et al. 1996; Randolph et al., 2007). Knockout of 
NGF results in an 80% decrease in the volume of sympathetic SCG neurons 
compared to wt littermates, while the number of vagal sensory neurons within 
the nodose ganglion remained normal (Crowley et al., 1994). Meanwhile, NT-3 
is responsible for 55% and 53% of DRG and SCG sympathetic neurons, 
respectively (Ernfors et al., 1994). Knockout of BDNF did not impact SCG 
density, while the nodose ganglion displayed a 44% decrease in volume at P0 
(Jones et al., 1994). Additionally, sympathetic innervation of several peripheral 
tissues, including the heart, kidneys, and bladder in mice deficient in both 
BDNF and p75 was determined to be unaltered (Jahed & Kawaja 2005). This 
study did not investigate GI tissues, leaving open the possibility that 
sympathetic innervation of the stomach or intestine could be impacted by 
BDNF. However, severing the splanchnic fibers of the sympathetic innervation 
to the gut does not affect food intake (Deutsch & Jang Ahn 1986), suggesting 
the meal pattern and meal microstructure results observed in the current study 
are not effects due to BDNF loss on the sympathetic nervous system.  
The enteric nervous system is another possible tissue in the GI tract that 
could become altered by loss of BDNF in the smooth muscle. Global 
heterozygous BDNF mutants (BDNF +/-) showed a 16% decrease in in 
myenteric plexus cell numbers in the jejunum of the intestine, which is not 
consistent with the effects observed here, making myenteric neuron targets 
unlikely to account for the increases in IGLE density, vagal sensory neurons in 
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the nodose ganglion, and satiation and satiety (Jones et al., 2001). Although it 
is possible the cell numbers of the myenteric plexus are not equivalent in the 
jejunum from this example and the duodenum, which was the level of the 
intestine under investigation in the present thesis. Murphy & Fox (2010) also 
demonstrated myenteric neuron density remained normal in the stomach of 
BDNF -/- global KO mice at P0.  It is also possible that BDNF contributed to the 
development or function of enteric or sympathetic innervation of the GI tract 
and subsequently affected GI reflexes, which could contribute to satiation and 
satiety. It has been shown that administration of BDNF enhances GI peristalsis 
by increasing serotonin and calcitonin gene-related peptide (CGRP) (Grider et 
al., 2006). However, similar effects on GI reflexes through alteration of the 
enteric and/or sympathetic nervous systems are likely not responsible for the 
increased satiation and satiety of BDNF SM -/- mice, as the BDNF SM -/-  
animals showed a decrease of BDNF, rather than an increase of BDNF which 
resulted in increased GI reflex activity.  
Deletion of BDNF from the smooth muscle to study the impact on the 
vagal afferents innervating this tissue could subsequently affect the 
development of the smooth muscle tissue itself, in addition to the vagal 
innervation innervating the tissue. Because BDNF is expressed strongly in the 
visceral organs, there may be an autocrine role for BDNF in the smooth muscle 
(Lommatzsch et al., 1999). If BDNF removal from the smooth muscle affects 
the development of the organs themselves, the visceral organs could become 
hypotrophic, and this degeneration of the organs could affect vagal innervation 
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and function indirectly, and could lead to the changes in feeding behavior 
observed here. An effect similar to this concept has been demonstrated with 
another organ system and growth factor. For example, NGF reduction in rats 
leads to severe testicular atrophy. These rats demonstrated reduced testes 
size and weight, with a 50% decrease in sperm production (Nylén et al., 1989). 
However, this is unlikely to occur, as neither the receptor for BDNF, trkB, nor 
its alternate receptor, p75, are expressed in the smooth muscle in mice 
(Lommatzsch et al., 1999). Additionally, there is no TrkB expression in many GI 
organs innervated by vagal afferents in humans, such as the esophagus, 
stomach, small intestine, colon, liver, and pancreas (Shibayama & Koizumi 
1996). The BDNF ligand for these receptors and the receptors themselves are 
only present in the vagal afferent neurons and their projections, and in enteric 
neurons (Ichikawa 2007; Kashiba et al., 2003; Robinson 1996; Zhuo & Helke 
1996; Ernfors et al., 1992). Up to 98% of neurons in the nodose ganglion have 
been shown to express TrkB mRNA (Kashiba et al., 2003). Based on this 
collection of evidence, BDNF in the smooth muscle cannot bind to its TrkB or 
p75 receptors to effect a response. 
Effects of SM BDNF on Long-Term Regulation of Food Intake  
and Body Weight 
As reported previously, global and CNS-specific genetic removal of 
BDNF has typically resulted in hyperphagia and obesity (Kernie et al., 2000; 
Rios et al., 2001; Unger et al., 2007; Liao et al., 2012; Fox et al., 2013). 
However, we found no differences in food intake, body weight, or body 
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composition between BDNF SM -/- mice and controls. There are several 
explanations for this discrepancy. It is possible that brain-specific removal of 
BDNF results in hyperphagia and obesity, while peripheral BDNF does not. 
There may be differences in central and peripheral mechanisms of BDNF 
regulation. In the smooth muscle, BDNF may play a role in development, rather 
than act as a feeding signal. However, Kamitakahara and Simerly (2012) 
similarly found no differences in food intake and body weight in mice with a 
VMH specific knockout of BDNF, using the promoter of the steroidogenic factor 
1 (SF-1) gene, which is restricted to SF-1 neurons in the VMH. In addition, they 
found a significant increase in axon density to the perifornical region of the LHA 
from the VMH in mice missing BDNF from the VMH compared to wt mice. 
Therefore, it seems increasingly likely that BDNF has several different roles in 
development and metabolic regulation in both the central and peripheral 
nervous systems.  
Additionally, compensatory mechanisms may be acting to maintain 
normal total food intake and body weight over time in BDNF SM -/- mice.  This 
has been demonstrated in the past by other neonatal genetic ablations of 
neuropeptides and hormones involved in the regulation of food intake and body 
weight (Erickson et al., 1996; Luquet et al., 2005; Ring & Zeltser 2010). For 
example, mice with a developmental KO of AgRP, where the mice are lacking 
AgRP from birth, showed normal food intake and energy homeostasis, which 
would suggest AgRP neurons were not important for food intake and energy 
balance (Erickson et al., 1996). However, it was later observed that deletion of 
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AgRP neurons in adult animals rapidly reduced food intake, and stimulation of 
these neurons led to overeating, even in sated animals (Qian et al., 2002; 
Aponte et al., 2011; Krashes et al., 2013). Therefore, AgRP neurons are 
important for regulation of food intake, but the acute functions of AgRP neurons 
were obscured because the original developmental KO of AgRP neurons were 
compensated for over time (Luquet et al., 2005; Morrison & Munzberg 2012). 
Because the KO utilized in this study occurred during development, it is 
possible compensatory mechanisms are responsible for the maintenance of 
normal total food intake and body weight in BDNF SM -/- mice. 
 The results presented in this thesis also shed light on some previously 
unexpected effects of targeting removal of BDNF to the smooth muscle utilizing 
a slightly different approach compared to the present study (Fox et al., 2013). 
As mentioned earlier, generation of SM22α-BDNF KO mutant mice resulted in 
global removal of one BDNF allele, while the other BDNF allele was removed 
from the smooth muscle. This approach was utilized to ensure high efficiency 
of BDNF deletion. Theoretically, in these mice approximately 100% BDNF 
should be removed from the smooth muscle and approximately 50% BDNF 
should be removed from the brain. This approach surprisingly resulted in mice 
that exhibited striking early-onset obesity and hyperphagia. One unexpected 
consequence for interpreting these interesting results was the difficulty in 
separating out the relative gut and brain contributions to the obesity and 
hyperphagia observed in SM22α-BDNF KO mice. This is because BDNF levels 
were reduced by varying amounts in several different tissues that are involved 
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in regulation of energy balance in these animals. In particular, BDNF mRNA 
levels in the brain of SM22α-BDNF KO mice in the Fox et al. 2013 study were 
lower than expected. For example, there was a 90% decrease in the 
hypothalamus compared to wt mice. This was surprising, as only a 50% 
decrease was predicted due to the one global BDNF allele missing in those 
mice. Therefore, it appeared the cre expression driven by SM22α is not as 
specific to the smooth muscle as had been reported in multiple studies (Li et 
al., 1996; Zhang et al., 2001; Lepore et al., 2005) and suggested that it was 
active in hypothalamic cells known to express BDNF (Wetmore et al., 1990; 
Conner et al., 1997; Xu et al., 2003; Unger et al., 2007). This was verified 
through the presence of BDNF expression in the hippocampus, anterior-lateral 
cerebral cortex, and the VMH of BDNFlox-lacZ reporter mice, indicating BDNF 
removal from these locations due to the SM22α promoter (Fox et al., 2013). 
Consequently, it was not possible to distinguish the relative contributions of 
BDNF loss from the gut and the brain to the hyperphagia and obesity of 
SM22α-BDNF KO mice. 
In the current study, both BDNF alleles were targeted to the smooth 
muscle, with no global removal of BDNF that had previously complicated 
interpretation of the increases in food intake and body weight observed in the 
Fox et al. (2013) study. Interestingly, despite use of the same SM22αcre 
promoter used in the Fox et al. (2013) study there were no differences in body 
weight between BDNF SM -/- mice and any other genotypes generated in the 
present set of experiments. This could imply the unexpected extreme 
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hyperphagia and obesity demonstrated by the SM22α-BDNF KO mice in the 
Fox et al. (2013) study were not due solely to the SM22αcre promoter 
expression that decreased BDNF levels in the anterior-lateral cerebral cortex, 
hippocampus and VMH. This finding is consistent with previous reports, as 
Kamitakahara & Simerly (2012) and Dhillon et al. (2006) found VMH-specific 
BDNF KO mice failed to develop obesity, although the VMH has been 
implicated as a primary site of BDNF action to regulate food intake within the 
hypothalamus (Xu et al., 2003; Unger et al., 2007; Wang et al., 2007; Godar et 
al., 2011). The hyperphagia and obesity as demonstrated by SM22α-BDNF KO 
mice in the Fox et al. (2013) study was likely due to the combination of 90% 
decrease in BDNF from the VMH and approximately 50% reductions of BDNF 
other brain regions (due to the global heterozygous BDNF KO in these mice) 
that cooperate with the VMH to regulate feeding and body weight. 
IGLE Distribution in the Intestine 
A novel finding in this study is the similarity of IGLE density throughout 
the first 8 cm of the duodenum. An initial high density of IGLEs in the proximal 
segment of the duodenum and a decrease in IGLE density from rostral to 
caudal down the length of the intestine has typically been reported (Berthoud et 
al., 1997; Phillips et al., 1997; Fox et al., 2000; Fox et al., 2001a; Wang et al., 
2012). However, in the present study, IGLE density was nearly identical in the 
0-4 and 4-8 cm segments of duodenum sampled. There are several reasons 




 The nodose ganglion is typically considered to be organized in a loosely 
viscerotopic arrangement, with neurons generally located more anteriorly within 
the nodose projecting to more anterior organs, and neurons with a more caudal 
location in the nodose innervating more posterior organs, however little is 
known about the specific organization of vagal innervation within the nodose 
(Altschuler et al., 1989; Zhuo et al., 1997). For example, neurons that project to 
the esophagus and the aortic depressor nerve are located in the rostral part of 
the nodose ganglion, and neurons that project to the stomach and pancreas 
are located more caudally within the nodose (Zhuo et al., 1997). However, 
these distinctions are not well defined, as the specific organization and 
projection patterns of neurons in the nodose ganglion are still unknown. 
Because little is known regarding the specific organization of vagal innervation 
of the GI tract within the nodose ganglion, it is hard to draw conclusions 
regarding the density and distribution of IGLEs in the stomach and intestine.  
 The method utilized to label IGLEs in the GI tract in this study and other 
studies, nodose injections of the nerve tracer WGA-HRP, is a powerful method 
to label nearly all of the vagal afferents innervating the GI tract. This tracer was 
utilized in this study because to date it selectively labels the highest percentage 
of vagal sensory innervation of the GI tract, at almost 100%. However, 
variables such as injection location within the nodose and experimenter 
variability could contribute to the different IGLE distribution patterns observed 
in the current study compared to other studies. Future studies should focus on 
mapping the exact injection site within the nodose ganglion and where these 
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neurons project to in the GI tract. It will also be instrumental to study IGLE 
density throughout the intestine, and include the jejunum and ileum to see if 
these regions have a higher IGLE density than previously considered. 
Separation of Sensory and Motor Vagal Pathways 
As discussed previously, the vagus is a mixed nerve, which consists of 
both sensory and motor components. An additional benefit of a BDNF smooth-
muscle specific KO is the ability to disentangle the separate contributions of the 
sensory and motor components of the vagus. A genetic approach is useful for 
the selective manipulation of vagal afferents without concomitantly damaging 
or manipulating the motor component of the vagus nerve, as both sub-
diagphragmatic surgical and chemical deafferentations have failed to eliminate 
the majority of sensory-specific vagal innervation to the GI tract. For example, 
surgical vagotomy severs both sensory and motor connections between the 
brain and gut, while application of the chemical neurotoxin capsaicin destroys 
only a subset of all vagal GI afferents.  
In the present study, the KO of BDNF is sensory-specific. This is 
because BDNF is not necessary for the survival of vagal motor neurons. For 
example, global KO of BDNF does not impact density of motor DMV neurons; 
however, there is a significant decrease in vagal sensory neurons in the 
nodose ganglion (Jones et al., 1994). In addition, Murphy & Fox (2010) showed 
no change in myenteric neurons or vagal efferents in the stomach of BDNF -/- 
mice compared to controls. Therefore, the increases in satiation and satiety 
observed in BDNF SM -/- mice are likely due to changes in vagal sensory 
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signaling, which is consistent with the increase in IGLE density in these mice. 
Although it is possible that any changes in sensory signaling can also affect the 
motor output response, which could contribute to changes in feeding behavior 
such as GI reflexes. This study is one of the first to provide evidence of vagal 
satiation signaling without altering vagal motor function or global expression 
levels of the gene of interest. 
Conclusions 
Smooth-muscle specific removal of BDNF results in increased vagal 
afferent innervation to the intestine, as demonstrated by increased IGLE 
density and increased number of large diameter longitudinal bundles. This 
effect appears to be mediated by increased survival of vagal sensory neurons, 
although increased branching of axon bundles may also play a role in the 
increased IGLE density observed in BDNF SM -/- mutants compared to 
controls. The increase in IGLE density and vagal bundles in BDNF SM -/- mice 
is associated with increases in satiation and satiety, as the mutant mice show 
decreased meal duration, decreased meal size, increased IMI, and increased 
satiety ratio. Consistent with this, BDNF SM -/- and control mice show the 
same initial feeding rate after a six hour fast. However, during the postingestive 
phase of food intake, BDNF SM -/- show increased suppression of food intake. 
It appears that BDNF’s normal role is to suppress the development of sensory 
vagal innervation in the intestine. This project reveals a novel role for BDNF in 
the development of vagal afferent innervation to the intestine. 
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Density of Vagal Elements Quantified in Control and BDNF SM -/- Mice 
__________________________________________________________ 




Longitudinal fibers 3.39 ± 0.47 3.37 ± 0.47 
Longitudinal bundles 5.39 ± 1.31 7.30 ± 1.31 
Circular fibers 2.37 ± 0.48 2.54 ± 0.48 




Longitudinal fibers 1.47 ± 0.34  1.48 ± 0.30 
Longitudinal bundles   1.98 ± 1.26 3.36 ± 1.19 
Circular fibers  1.26 ± 0.33 1.75 ± 0.31 
Circular bundles  1.95 ± 1.11 2.83 ± 1.05 
__________________________________________________________ 
Total (0-8 cm) 
__________________________________________________________ 
Longitudinal fibers   2.59 ± 0.319 2.52 ± 0.31 
Longitudinal bundles   4.07 ± 1.11 5.55 ± 1.11 
Circular fibers 1.94 ± 0.36 2.23 ± 0.36 






Number of Longitudinal and Circular Bundles in Control and BDNF SM -/- Mice 
_______________________________________________________________ 
 Control BDNF SM -/- 
_______________________________________________________________ 
Diameter of longitudinal bundles (m) 
_______________________________________________________________ 
0.5-1.0 27 ± 8.83 31.11 ± 4.77 
1.5-2.0 19 ± 5.04 41.44 ± 9.29 
2.5-3.0 6.44 ± 1.96 16.11 ± 4.59 
3.5-4.0 1.33 ± 0.37 4.89 ± 1.02 
4.5-5.0 0.22 ± 0.15 1.44 ± 0.44 
5.5-6.0 0.33 ± 0.17 0.22 ± 0.15 
_______________________________________________________________ 
Diameter of circular bundles (m) 
_______________________________________________________________ 
0.5-1.0 20.56 ± 7.226 24.45 ± 3.56 
1.5-2.0 14.12 ± 3.58 24.89 ± 6.429 
2.5-3.0 3.39 ± 1.349 9.45 ± 3.54 
3.5-4.0 0.78 ± 0.468 3.0 ± 1.218 
4.5-5.0 0.12 ± 0.12 0.56 ± 0.24 











Estimated Number of Neurons in the Nodose Ganglia in Control (n = 9) and 
BDNF SM -/- (n = 14) Mutant Mice and Percentage of Cell Increase in Mutant 
Mice and Percentage of Cell Increase in Mutants 
_______________________________________________________________ 
 Control BDNF SM -/- Cell Increase (%) p Value 
_______________________________________________________________ 
Right nodose  1737 ± 227 2819 ± 277 62 0.012* 
Left nodose  1878 ± 189  2505 ± 292  33 0.129 
Total 3615 ± 315 5324 ± 488 47 0.017* 
_______________________________________________________________ 


































































































































































































































































































































































































































































































































































































































































































Generation 1: SM22αcre/cre; BDNF+/+   X            SM22α+/+; BDNFlox/lox 
 
 
Generation 2: SM22αcre/+; BDNF+/lox                          X   SM22αcre/+; BDNF+/lox                      
 
Generation 3: SM22α+/+; BDNF +/+ (wt) 
 SM22αcre/+; BDNF+/+ (cre only) 
 SM22α+/+; BDNFlox/lox (double lox) 
 SM22α+/+; BDNF+/lox (single lox) 
 SM22αcre/+; BDNF+/lox (BDNF SM +/-) 
 SM22αcre/+; BDNFlox/lox (BDNF SM -/-) 
    
These initial matings (SM
cre/cre x BDNF lox/lox) result in all of the offspring  being double 
heterozygotic transgenic mice needed for the next round of mating (Generation 2: SMcre/+ ; 
BDNF +/lox). These mice are then mated among themselves (SMcre/+; BDNF +/lox x SMcre/+ ; 




Figure 2. Breeding scheme used to generate BDNF SM -/- mice and 
associated control groups.  
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Figure 3. BDNF mRNA levels in BDNF SM -/- were decreased in GI tissues 
compared to controls, indicating the SM22α promoter successfully targeted KO 
of BDNF to the smooth muscle. Bars represent relative percent BDNF ± SEM 
mRNA expression in CNS and GI tissues of BDNF SM -/- mice compared to 
controls normalized to the reference gene β-actin.  
  




Figure 4. Body weight curves of all genotypes generated from weaning at 3 
weeks of age until 4 months of age in males (A) and females (B). Body weight 
does not differ between any of the genotypes.  
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Figure 5. Morphology of IGLEs in the stomach of (A) control and (B) BDNF SM 
-/- mice. IGLE morphology and density remained normal in BDNF SM -/- mice. 




































































































Figure 6. BDNF SM -/- mice displayed normal IGLE density in the stomach 
compared to controls. (A) Total average IGLE density. (B) IGLE density in each 
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Figure 7. Morphology of IGLEs in the duodenum of (A) control and (B) BDNF 
SM -/- mice is normal. However, there is a significant increase in IGLE density 
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Figure 8. Photomontages of IGLE morphology and density in the intestine of 
(A) control and (B) BDNF SM -/- mice.  BDNF SM -/- mice demonstrated an 
increase in IGLE density in the intestine compared to controls. Arrows denote 
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Figure 9. Quantification of vagal afferent innervation shows increased IGLE 
density across the first 0-8 cm in the intestine of BDNF SM -/- mice compared 
to controls. Density of IGLEs in the 0-4 and 4-8 cm portions of the duodenum 
were nearly significant. 
  




Figure 10. BDNF SM -/- mice demonstrated a trend toward increased 
longitudinal bundle density in the (A) total (0-8 cm) of the duodenum (B) 0-4 cm 
and (C) 4-8 duodenum of the intestine. 
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Figure 11. BDNF SM -/- mice demonstrated significantly increased number of 
larger-diameter longitudinal axon bundles compared to control mice (A), while 
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Figure 12. BDNF SM -/- mice showed a significant increase in vagal sensory 
neurons compared to controls. Images shown are representative examples of 
nodose ganglia in control (A) and BDNF SM -/- mice (B), while (C) depicts 
number of vagal sensory neurons on the left and right sides, and the total of 
































































































































Figure 13. There were no differences in total food intake or body weight during 
meal pattern collection at 3-4 months of age. (A) Daily food intake over days 5-
22 of meal pattern collection on a balanced pellet diet. (B) Daily body weight 
over days 5-22 of meal pattern collection on a balanced pellet diet. 
B 
A 
Body weight  

































































Figure 14. There were no differences in total grams of lean mass or fat mass 
during meal pattern collection at 3-4 months of age in either males (A) or 
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Figure 15. There were no differences in lean mass or fat mass expressed as 
percent of body mass during meal pattern collection at 3-4 months of age in 
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Figure 16. BDNF SM -/- mice showed increased satiation compared to wt mice, 
as shown by decreased total meal duration (A), decreased average meal 
duration (B) and decreased meal size (C) compared to wt mice. 
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Figure 17. BDNF SM -/- mice showed increased satiety compared to wt mice, 
as shown by increased total IMI (A), a trend towards an increased average IMI 
(B) and increased satiety ratio (C) compared to wt mice. 
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Figure 18. BDNF SM -/- compensated for increased satiation with increased 
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Figure 19. Rate of food intake across the first 30 min meal after a 6 hr fast and 
averaged across days 5-22 are shown by each minute (A) and averaged 




Feeding rate – 1st 30 minutes  
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Figure 20. Food intake from minutes 6-30. BDNF SM -/- mice show increased suppression 
during the late decay phase of food intake. The rate of food intake across minutes 6-30 is 
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